Outpatient and Emergency Department Visits2020/06/05 · in people aged 65 years and older (254.7 per 100,000) and 50-64 years (126.2 per 100,000). certificates are processed Based

Nationally, levels of influenza-like illness (ILI) and COVID-19-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2, the virus that causes COVID-19, continue to decline or remain stable at low levels. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed.

Key Updates for Week 22, ending May 30, 2020

The national percentage of respiratory specimens testing positive for SARS-CoV-2 at public health, clinical and commercial laboratories decreased from week 21 to week 22; however, percent positivity increased slightly in four regions. National percentages by type of laboratory:

• Public health laboratories – decreased from 6.8% during week 21 to 6.0% during week 22; • Clinical laboratories – decreased from 6.0% during week 21 to 5.9% during week 22; • Commercial laboratories – decreased from 6.5% during week 21 to 5.9% during week 22.

Two surveillance indicators are being used to track outpatient or emergency department (ED) visits for illness with symptoms compatible with COVID-19.

• Nationally, the percentages of visits for ILI and CLI decreased or remained stable at low levels, compared to last week. Levels of ILI are below baseline nationally for the seventh week and in all 10 surveillance regions for the past five to eight weeks.

Recent changes in health care seeking behavior, including increasing use of telemedicine, recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing, are likely affecting data reported from both networks, making it difficult to draw conclusions at this time. Tracking these systems moving forward will give additional insight into illness related to COVID-19.

Cumulative COVID-19-associated hospitalization rates since March 1, 2020, are updated weekly. The overall cumulative COVID-19 hospitalization rate is 82.0 per 100,000, with the highest rates in people aged 65 years and older (254.7 per 100,000) and 50-64 years (126.2 per 100,000).

Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 13.7% during week 21 to 8.4% during week 22 but remained above baseline. This is the sixth week of a declining percentage of deaths due to PIC, but this percentage may change as more death certificates are processed, particularly for recent weeks.

Virus

Outpatient and Emergency Department Visits

Severe Disease

Public Health, Commercial and Clinical Laboratories

Outpatient Influenza-Like Illness Network (ILINet) and National Syndromic Surveillance Program (NSSP)

Hospitalizations Mortality

All data are preliminary and may change as more reports are received. A description of the surveillance systems summarized in COVIDView, including methodology and detailed descriptions of each data component, is available on the surveillance methods page.

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html

2 COVIDView Week 22, ending May 30, 2020

Key Points

o Nationally, the percentages of laboratory specimens testing positive for SARS-CoV-2 with a molecular assay decreased compared to last week; however, there are two developments in particular worth noting:

o The percent positivity increased in four HHS surveillance regions: Region 4 (the southeast), Region 6 (the south central), Region 9 (the west coast) and Region 10 (the Pacific northwest).

o While the number of specimens from children <18 years of age tested is low (<5% of all specimens tested in public health and commercial laboratories), the percentage testing positive for SARS-CoV-2 in this age group continued to either trend upward or remain relatively stable while other age groups have seen consistent declines in percent positivity in recent weeks.

o Nationally, visits to outpatient providers and emergency departments (EDs) for illnesses with symptoms consistent with COVID-19 continued to decline or remain stable at low levels. Outpatient ILI visits are below baseline nationally and in all regions of the country.

o The decrease in the percentage of people presenting for care with ILI and CLI may be due to a decline in COVID-19 illness, which could be in part a result of widespread adoption of social distancing, in addition to decreases in healthcare seeking behavior.

o There has been very little influenza virus activity in recent weeks.

o The overall cumulative COVID-19 associated hospitalization rate is 82.0 per 100,000, with the highest rates in people 65 years of age and older (254.7 per 100,000) followed by people 50-64 years (126.2 per 100,000). Hospitalization rates are cumulative and will increase as the COVID-19 pandemic continues.

o Non-Hispanic American Indian or Alaska Native persons have a rate approximately 5 times that of non-Hispanic White persons, non-Hispanic Black persons have a rate approximately 4.5 times that of non-Hispanic White persons, while Hispanic or Latino persons have a rate approximately 3.5 times that of non-Hispanic White persons.

o Cumulative hospitalization rates for COVID-19 in adults (18-64 years) at this time are higher than cumulative end-of-season hospitalization rates for influenza over each of the past 5 influenza seasons.

o For people 65 years and older, current cumulative COVID-19 hospitalization rates are within ranges of cumulative influenza hospitalization rates observed at comparable time points* during recent influenza seasons.

o For children (0-17 years), cumulative COVID-19 hospitalization rates are much lower than cumulative influenza hospitalization rates at comparable time points* during recent influenza seasons.

o Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 13.7% during week 21 to 8.4% during week 22. This is the sixth week during which a declining percentage of deaths due to PIC has been recorded; however, the percentage remains above the epidemic threshold, and is now similar to what has been observed at the peak of some influenza seasons. The percentage may change as additional death certificates for deaths during recent weeks are processed.

*Number of weeks since 10% of specimens tested positive for SARS-CoV-2 and influenza, respectively.


U.S. Virologic Surveillance The number of specimens tested for SARS-CoV-2 using a molecular assay and reported to CDC by public health laboratories and a subset of clinical and commercial laboratories in the United States are summarized below. All laboratories are performing primary diagnostic functions; therefore, the percentage of specimens testing positive across laboratory types can be used to monitor overall trends in COVID-19 activity. As the outbreak progresses, it is possible that different types of laboratories will take on different roles, and the data interpretation may need to change. Summary of Laboratory Testing

Results Reported to CDC* Week 22

(May 24 – May 30, 2020) Cumulative since

March 1, 2020 No. of specimens tested 1,054,626 10,337,330

Public Health Laboratories 175,585 1,426,171 Clinical Laboratories 88,660 922,190

Commercial Laboratories 790,381 7,988,969 No. of positive specimens (%) 62,403 (5.9%) 1,239,169 (12.0%)

Public Health Laboratories 10,529 (6.0%) 163,645 (11.5%) Clinical Laboratories 5,206 (5.9%) 75,477 (8.2%)

Commercial Laboratories 46,668 (5.9%) 1,000,047 (12.5%)

Public Health Laboratories

* Commercial and clinical laboratory data represents select laboratories and does not capture all tests performed in the United States.


Clinical Laboratories

Commercial Laboratories

* Commercial laboratories began testing for SARS-CoV-2 in early March, but the number and geographic distribution of reporting commercial laboratories became stable enough to calculate a weekly percentage of specimens testing positive as of March 29, 2020. Additional virologic surveillance information: Surveillance Methods

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#virologic


Outpatient/Emergency Department Illness Two syndromic surveillance systems are being used to monitor trends in outpatient and emergency department visits that may be associated with COVID-19 illness. Each system monitors a slightly different syndrome, and together these systems provide a more comprehensive picture of mild to moderate COVID-19 illness than either would individually. Both systems are currently being affected by recent changes in healthcare seeking behavior, including increased use of telemedicine, compliance with recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing. These changes affect the numbers of people seeking care in the outpatient and ED settings and their reasons for doing so. ILINet The U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) provides data on visits for influenza-like illness (ILI) (fever [≥100○F] and cough and/or sore throat) to approximately 2,600 primary care providers, emergency departments and urgent care centers in all 50 states, Puerto Rico, the District of Columbia and the U.S. Virgin Islands. Mild COVID-19 illness presents with symptoms similar to ILI, so ILINet is being used to track trends of mild to moderate COVID-19 illness and allows for comparison with prior influenza seasons. Nationwide during week 22, 0.9% of patient visits reported through ILINet were due to ILI. This percentage is well below the national baseline of 2.4% and represents the tenth week of decline after three weeks of increase beginning in early March. The percentage of visits for ILI in week 22 remains low among all age groups. Nationally, laboratory-confirmed influenza activity as reported by clinical laboratories is at levels usually seen during summer months which, along with changes in healthcare seeking behavior and the impact of social distancing, is likely contributing to the low level of ILI activity.

* Age-group specific percentages should not be compared to the national baseline.

https://www.cdc.gov/flu/weekly/#ClinicalLaboratories

https://www.cdc.gov/flu/weekly/#ClinicalLaboratories


On a regional level, the percentage of outpatient visits for ILI ranged from 0.5% to 1.3% during week 22. All ten regions are at low levels and below their region-specific baselines. Note: In response to the COVID-19 pandemic, new sites will be enrolled in ILINet throughout the summer. This will result in an increase in patient visits and the percentage of visits for ILI may change in comparison to previous weeks. During week 21, new sites were added in Regions 1, 4, and 6. While these regions remain below baseline levels for ILI, these system changes should be kept in mind when drawing conclusions from these data. Any changes in ILI due to changes in respiratory virus circulation will be highlighted here. ILI Activity Levels Data collected in ILINet are used to produce a measure of ILI activity for all 50 states, Puerto Rico, the District of Columbia and New York City. The mean reported percentage of visits due to ILI for the current week is compared to the mean reported during non-influenza weeks, and the activity levels correspond to the number of standard deviations below, at or above the mean. The number of jurisdictions at each activity level during week 22 and the change compared to the previous week are summarized in the table below and shown in the following maps. The decreasing percentage of visits for ILI described above are reflected in this week’s ILI activity levels.

Activity Level

Number of Jurisdictions Week 22

(Week ending May 30, 2020)

Compared to Previous Week

Very High 0 No change High 0 -1 Moderate 1 +1 Low 1 -1 Minimal 51 +2 Insufficient Data 1 -1

*Data collected in ILINet may disproportionally represent certain populations within a state and may not accurately depict the full picture of influenza activity for the whole state. Differences in the data presented here by CDC and independently by some state health departments likely represent differing levels of data completeness with data presented by the state likely being the more complete.

ILI Activity Level Map, Week 21, Ending May 23, 2020 ILI Activity Level Map, Week 22, Ending May 30, 2020

https://www.hhs.gov/about/agencies/iea/regional-offices/index.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html


National Syndromic Surveillance Program (NSSP): Emergency Department (ED) Visits NSSP is a collaboration among CDC, federal partners, local and state health departments and academic and private sector partners to collect, analyze and share electronic patient encounter data received from multiple healthcare settings. To track trends of potential COVID-19 visits, visits for COVID-19-like illness (CLI) (fever and cough or shortness of breath or difficulty breathing or presence of a coronavirus diagnosis code) and ILI to a subset of emergency departments in 47 states are being monitored. Nationwide during week 22, 1.8% of emergency department visits captured in NSSP were due to CLI and 0.6% were due to ILI. This is the tenth week of decline in the percentage of visits for ILI and the eighth week of declining percentage of visits for CLI. Compared to week 21, all 10 HHS regions had declining percentages of visits for CLI during week 22; all 10 regions also had declining or stable percentages of visits for ILI.

Additional information about medically attended outpatient and emergency department visits for ILI and CLI: Surveillance Methods Hospitalizations The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) conducts population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in select counties participating in the Emerging Infections Program (EIP) and the Influenza Hospitalization Surveillance Project (IHSP).

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2019

4020

1941

2019

4220

1943

2019

4420

1945

2019

4620

1947

2019

4820

1949

2019

5020

1951

2019

5220

2001

2020

0220

2003

2020

0420

2005

2020

0620

2007

2020

0820

2009

2020

1020

2011

2020

1220

2013

2020

1420

2015

2020

1620

2017

2020

1820

2019

2020

2020

2021

2020

2220

2023

2020

2420

2025

Perc

ent o

f Tot

al E

D Vi

sits

Week

NSSP: Percentage of Visits for Influenza-Like Illness (ILI) and COVID-19-Like Illness (CLI) to Emergency Departments

Weekly National Summary, September 29, 2019 - May 30, 2020

Percent of Visits for CLIPercent of Visits for ILI

https://www.hhs.gov/about/agencies/iea/regional-offices/index.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#outpatient


A total of 26,623 laboratory-confirmed COVID-19-associated hospitalizations were reported by sites between March 1, 2020, and May 30, 2020. The overall cumulative hospitalization rate was 82.0 per 100,000 population. Among the 0-4 years, 5-17 years, 18-49 years, 50-64 years, and ≥ 65 years age groups, the highest rate of hospitalization is among adults aged ≥ 65 years (254.7 per 100,000), followed by adults aged 50-64 years (126.2 per 100,000) and adults aged 18-49 years (46.7 per 100,000).

Within the 18-49 years and ≥ 65 years age groups, the cumulative hospitalization rates increased with increasing age.

Age Group Cumulative Rate per 100,000 Population Overall 82.0 0-4 years 4.9 5-17 years 2.4 18-49 years 46.7 18-29 years 23.7 30-39 years 46.2 40-49 years 77.1

50-64 years 126.2 65+ years 254.7 65-74 years 185.7 75-84 years 307.5

85+ years 470.6


Among the 0-4 years and 5-17 years age groups, there appears to be a slight upward trend in weekly hospitalization rates, though these rates are limited by smaller case counts and may change as additional data are received. Weekly rates in the 18-29 years age group have been holding steady, while weekly rates have been declining in all other age groups. Among the 26,623 laboratory-confirmed COVID-19-associated hospitalized cases, 21,282 (79.9%) had information available on race and ethnicity while collection of race and ethnicity data was still pending for 5,341 (20.1%) cases. Of the 21,282 cases with race and ethnicity data, 35.5% were non-Hispanic White, 33.5% were non-Hispanic Black, 18.2% were Hispanic or Latino, 4.7% were non-Hispanic Asian or Pacific Islander, and 1.5% were non-Hispanic American Indian or Alaska Native persons. Persons of multiple races represented 0.2% of cases, and 6.4% of cases had unknown race and ethnicity. In comparison, the COVID-NET catchment area population includes 58.8% non-Hispanic White, 17.7% non-Hispanic Black, 14.0% Hispanic or Latino, 8.8% non-Hispanic Asian or Pacific Islander, and 0.7% non-Hispanic American Indian or Alaska Native residents. Additional data on race and ethnicity are available. COVID-19-associated hospitalization rates by race/ethnicity are calculated using hospitalized COVID-NET cases with known race and ethnicity for the numerator and NCHS bridged-race population estimates (https://www.cdc.gov/nchs/nvss/bridged_race.htm) for the denominator. Rates are adjusted to account for differences in age distributions within race/ethnicity strata in the COVID-NET catchment area; the age strata used for the adjustment include 0-17, 18-49, 50-64, 65-74, 75-84, and ≥ 85 years. Age-adjusted hospitalization rates are highest among non-Hispanic American Indian or Alaska Native and non-Hispanic Black persons, followed by Hispanic or Latino persons. Non-Hispanic American Indian or Alaska Native persons have a rate approximately 5 times that of non-Hispanic White persons, non-Hispanic Black persons have a rate approximately 4.5 times that of non-Hispanic White persons, while Hispanic or Latino persons have a rate approximately 3.5 times that of non-Hispanic White persons.

166.8149.5

117.4

38.9 33.5

020406080

100120140160180

Non-HispanicAmerican Indianor Alaska Native

Non-HispanicBlack

Hispanic/Latino Non-HispanicAsian

Non-HispanicWhite

Rate

per

100

,000

pop

ulat

ion

Race and Ethnicity

Age-adjusted COVID-19-associated hospitalization rates by race and ethnicity — COVID-NET, March 1–May 30, 2020

https://gis.cdc.gov/grasp/covidnet/COVID19_3.html

https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html

https://www.cdc.gov/nchs/nvss/bridged_race.htm


Among 6,000 hospitalized adults with information on underlying medical conditions, 91.6% had at least one reported underlying medical condition. The most commonly reported were hypertension, obesity, chronic metabolic disease, and cardiovascular disease.

Additional data on demographics, signs and symptoms at admission, underlying conditions, interventions, outcomes, and discharge diagnoses, stratified by age, sex, and race and ethnicity, are available. Additional hospitalization surveillance information: Surveillance Methods | Additional rate data | Additional demographic and clinical data


https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#hospitalization





Mortality Surveillance The National Center for Health Statistics (NCHS) collects death certificate data from vital statistics offices for all deaths occurring in the United States. Based on death certificate data available on June 4, 2020, 8.4% of all deaths occurring during the week ending May 30, 2020 (week 22) were due to pneumonia, influenza or COVID-19 (PIC). This is the sixth week of a declining percentage of deaths due to PIC; however, the percentage remains above the epidemic threshold of 6.3% for week 22. Data for recent weeks are incomplete, and the PIC percentage may increase as more death certificates representing deaths during these weeks are processed. Weekly mortality surveillance data include a combination of machine coded and manually coded causes of death collected from death certificates. Percentages of deaths due to PIC are higher among manually coded records than more rapidly available machine coded records. Due to the additional time needed for manual coding, the initially reported PIC percentages may be lower than percentages calculated from final data.

*Data during recent weeks are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes.

Additional NCHS mortality surveillance information: Surveillance Methods | Provisional Death Counts for COVID-19 Report prepared: June 4, 2020

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#mortality

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm


U.S. State and Local Public Health Laboratories Reporting to CDC March 1, 2020 - May 30, 2020

Data as of June 4, 2020

National

Week

No. of Labs

Total (includes age unknown) 0-4 years 5-17 years 18-49 years 50-64 years 65+ years

Spec Tested # Pos % Pos

Spec Tested

# Pos

% Pos

Spec Tested # Pos

% Pos

Spec Test-ed # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202010 77 8,110 973 12.0 222 10 4.5 582 42 7.2 3,139 318 10.1 1,926 247 12.8 2,095 331 15.8

202011 85 35,285 3,477 9.9 965 20 2.1 1,953 83 4.2 15,370 1,369 8.9 8,290 983 11.9 7,828 942 12.0

202012 87 69,253 6,795 9.8 1,559 36 2.3 2,312 86 3.7 31,613 2,643 8.4 16,011 1,805 11.3 16,201 2,083 12.9

202013 89 65,832 10,686 16.2 1,246 46 3.7 1,418 79 5.6 29,531 3,780 12.8 15,426 2,897 18.8 17,503 3,755 21.5

202014 89 78,593 13,917 17.7 1,118 63 5.6 1,447 168 11.6 34,433 4,464 13.0 18,648 3,593 19.3 22,403 5,534 24.7

202015 88 82,681 15,048 18.2 907 42 4.6 1,609 168 10.4 34,836 4,402 12.6 19,881 3,629 18.3 25,010 6,722 26.9

202016 86 83,668 15,209 18.2 779 64 8.2 1,467 147 10.0 36,082 5,254 14.6 19,041 3,324 17.5 25,905 6,347 24.5

202017 85 129,614 21,277 16.4 892 53 5.9 2,516 332 13.2 58,947 8,594 14.6 29,107 4,697 16.1 37,393 7,457 19.9

202018 86 150,058 19,294 12.9 1,181 108 9.1 3,914 467 11.9 65,866 8,013 12.2 34,385 4,109 11.9 44,081 6,527 14.8

202019 85 162,774 17,417 10.7 1,708 100 5.9 4,349 512 11.8 71,936 7,680 10.7 37,877 3,557 9.4 46,273 5,484 11.9

202020 86 178,681 15,000 8.4 1,363 104 7.6 5,022 503 10.0 77,263 6,854 8.9 40,740 2,901 7.1 53,781 4,573 8.5 202021 83 206,037 14,023 6.8 1,685 122 7.2 5,864 611 10.4 91,665 6,531 7.1 45,642 2,694 5.9 60,540 4,009 6.6 202022 79 175,585 10,529 6.0 1,232 114 9.3 4,607 504 10.9 76,872 4,913 6.4 38,898 1,995 5.1 53,648 2,994 5.6

Total . 1,426,171 163,645 11.5 14,857 882 5.9 37,060 3,702 10.0 627,553 64,815 10.3 325,872 36,431 11.2 412,661 56,758 13.8

Region 1 (CT, ME, MA, NH, RI, VT)

Week No. of Labs


202010 8 715 142 19.9 202011 17 3308 283 8.6 202012 18 9617 732 7.6 202013 16 4636 701 15.1 202014 15 6168 1623 26.3 202015 18 8243 2424 29.4 202016 13 11652 2651 22.8 202017 12 17154 2981 17.4 202018 12 11279 1814 16.1 202019 11 10036 1623 16.2 202020 11 11379 1118 9.8 202021 18 14225 1074 7.6 202022 14 12006 751 6.3

Total 120418 17917 14.9


Region 2 (NJ, NY, PR)

Week No. of Labs


202010 6 1434 193 13.5 202011 21 5421 788 14.5 202012 26 10498 1443 13.8 202013 21 6776 2250 33.2 202014 24 7056 2288 32.4 202015 19 6413 1707 26.6 202016 19 5077 1243 24.5 202017 18 5816 1051 18.1 202018 18 7560 954 12.6 202019 16 10664 874 8.2 202020 14 14891 683 4.6 202021 14 8910 359 4.0 202022 15 8628 276 3.2

Total 99144 14109 14.2

Region 3 (DE, DC, MD, PA, VA, WV)

Week No. of Labs


202010 8 334 30 9.0 202011 22 1651 250 15.1 202012 22 2685 377 14.0 202013 19 4145 783 18.9 202014 18 5559 1348 24.3 202015 20 5339 1835 34.4 202016 21 4975 1839 37.0 202017 16 6151 2079 33.8 202018 17 7062 1664 23.6 202019 20 5803 1293 22.3 202020 16 8738 1484 17.0 202021 22 9192 1211 13.2 202022 23 9471 1003 10.6

Total 71105 15196 21.4


Region 4 (AL, FL, GA, KY, MS, NC, SC, TN)

Week No. of Labs


202010 17 759 69 9.1 202011 29 4483 449 10.0 202012 38 10841 1000 9.2 202013 31 12571 1723 13.7 202014 32 14924 2121 14.2 202015 31 17887 2658 14.9 202016 30 14105 2187 15.5 202017 26 17566 2623 14.9 202018 25 18604 2608 14.0 202019 30 21341 2294 10.8 202020 30 23614 2372 10.0 202021 33 31051 2168 7.0 202022 29 36455 2300 6.3

Total 224201 24572 11.0

Region 5 (IL, IN, MI, MN, OH, WI)

Week No. of Labs


202010 18 759 35 4.6 202011 28 7071 492 7.0 202012 31 12255 1227 10.0 202013 27 12146 2654 21.9 202014 29 14477 3067 21.2 202015 29 14278 2772 19.4 202016 24 12078 2211 18.3 202017 23 23302 5099 21.9 202018 22 39302 6094 15.5 202019 23 33560 4660 13.9 202020 28 36336 3376 9.3 202021 24 36451 3056 8.4 202022 27 31303 1901 6.1

Total 273318 36644 13.4


Region 6 (AR, LA, NM, OK, TX)

Week No. of Labs


202010 9 278 11 4.0 202011 23 2768 329 11.9 202012 31 4496 863 19.2 202013 30 4778 850 17.8 202014 28 5990 1005 16.8 202015 24 5637 910 16.1 202016 26 4269 896 21.0 202017 23 11226 1044 9.3 202018 23 13864 1149 8.3 202019 21 19474 1291 6.6 202020 26 19536 1597 8.2 202021 27 27358 1589 5.8 202022 24 14632 1032 7.1

Total 134306 12566 9.4

Region 7 (IA, KS, MO, NE)

Week No. of Labs


202010 7 268 43 16.0 202011 16 1113 70 6.3 202012 18 2920 148 5.1 202013 12 3665 330 9.0 202014 14 4547 513 11.3 202015 11 5746 704 12.3 202016 12 7683 1678 21.8 202017 12 15104 3787 25.1 202018 10 10706 2223 20.8 202019 20 13779 2399 17.4 202020 18 11253 1891 16.8 202021 17 11619 1652 14.2 202022 15 11271 1273 11.3

Total 99674 16711 16.8


Region 8 (CO, MT, ND, SD, UT, WY)

Week No. of Labs


202010 7 563 28 5.0 202011 15 4234 347 8.2 202012 14 7643 353 4.6 202013 16 7546 390 5.2 202014 13 8746 613 7.0 202015 13 7820 451 5.8 202016 14 9589 746 7.8 202017 14 16537 1068 6.5 202018 16 22759 798 3.5 202019 18 21872 816 3.7 202020 16 26902 922 3.4 202021 18 34921 1315 3.8 202022 16 25866 566 2.2

Total 194998 8413 4.3

Region 9 (AZ, CA, GU, HI, NV)

Week No. of Labs


202010 26 1419 150 10.6 202011 40 3549 373 10.5 202012 48 5177 403 7.8 202013 45 6400 705 11.0 202014 43 7436 999 13.4 202015 41 8081 1368 16.9 202016 36 9200 1466 15.9 202017 36 12215 1325 10.9 202018 33 14453 1659 11.5 202019 36 20526 1857 9.1 202020 40 20165 1308 6.5 202021 37 24677 1279 5.2 202022 36 18737 995 5.3

Total 152035 13887 9.1


Region 10 (AK, ID, OR, WA)

Week No. of Labs


202010 8 1581 272 17.2 202011 19 1687 96 5.7 202012 14 3121 249 8.0 202013 15 3169 300 9.5 202014 15 3690 340 9.2 202015 10 3237 219 6.8 202016 12 5040 292 5.8 202017 12 4543 220 4.8 202018 13 4469 331 7.4 202019 14 5719 310 5.4 202020 12 5867 249 4.2 202021 13 7633 320 4.2 202022 12 7216 432 6.0

Total 56972 3630 6.4


U.S. Clinical Laboratories Reporting SARS-CoV-2 Test Results to CDC March 8, 2020 - May 30, 2020


National

Week Number of Labs Reporting Spec Tested # Pos % Pos

202011 28 2493 147 5.9 202012 45 18759 1169 6.2 202013 56 45031 3957 8.8 202014 67 55919 6250 11.2 202015 85 56303 7107 12.6 202016 99 67222 7381 11.0 202017 105 87177 9078 10.4 202018 112 108149 9761 9.0 202019 119 126887 8894 7.0 202020 114 136776 8763 6.4 202021 107 128814 7764 6.0 202022 63 88660 5206 5.9

Total 922190 75477 8.2


U.S. Commercial Laboratories Reporting to CDC March 29, 2020 – May 30, 2020

Data as of June 4, 2020 National

Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos




202014 6 541,428 125,150 23.1 8,309 529 6.4 13,515 1,866 13.8 289,240 61,077 21.1 130,280 35,082 26.9 75,905 20,993 27.7

202015 6 500,473 114,327 22.8 6,759 600 8.9 12,910 2,153 16.7 258,864 55,334 21.4 124,401 31,673 25.5 73,256 19,212 26.2

202016 6 507,827 98,660 19.4 6,378 579 9.1 15,140 2,357 15.6 242,616 46,174 19.0 122,588 24,901 20.3 78,951 16,151 20.5

202017 6 614,141 97,397 15.9 7,755 686 8.8 19,731 2,990 15.2 295,989 48,620 16.4 152,349 24,051 15.8 110,092 16,797 15.3

202018 6 741,684 96,023 12.9 9,851 834 8.5 24,615 3,621 14.7 352,475 49,195 14.0 181,616 22,279 12.3 137,866 15,942 11.6

202019 6 871,389 85,931 9.9 12,160 951 7.8 30,153 3,845 12.8 400,899 44,670 11.1 211,771 18,808 8.9 174,517 13,784 7.9

202020 6 1,091,687 83,548 7.7 15,519 1,151 7.4 38,627 4,291 11.1 493,501 43,730 8.9 264,002 17,393 6.6 227,987 13,198 5.8

202021 6 1,310,726 85,841 6.5 17,016 1,292 7.6 44,031 4,726 10.7 610,622 46,239 7.6 312,144 17,155 5.5 261,147 12,360 4.7

202022 6 790,381 46,668 5.9 10,043 687 6.8 25,782 2,721 10.6 364,350 25,008 6.9 190,975 9,391 4.9 161,721 6,826 4.2

Total 6,969,736 833,545 12.0 93,790 7,309 7.8 224,504 28,570 12.7 3,308,556 420,047 12.7 1,690,126 200,733 11.9 1,301,442 135,263 10.4


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos



Spec Tested # Pos

% Pos

202014 6 42,059 10,442 24.8 474 34 7.2 824 157 19.1 21,466 4,902 22.8 10,982 2,950 26.9 6,581 1,986 30.2

202015 6 41,140 10,589 25.7 450 43 9.6 926 182 19.7 20,086 4,847 24.1 11,105 2,909 26.2 6,658 2,104 31.6

202016 6 41,036 10,330 25.2 424 74 17.5 1,111 229 20.6 17,811 4,321 24.3 9,595 2,320 24.2 6,384 1,872 29.3

202017 5 51,287 10,414 20.3 559 98 17.5 1,628 333 20.5 24,824 4,988 20.1 13,166 2,448 18.6 8,924 2,098 23.5

202018 6 64,854 10,547 16.3 670 93 13.9 1,923 389 20.2 31,679 5,027 15.9 16,237 2,375 14.6 11,714 2,265 19.3

202019 6 68,820 9,481 13.8 733 100 13.6 2,115 398 18.8 31,581 4,477 14.2 17,141 2,098 12.2 14,433 2,058 14.3

202020 6 91,197 8,413 9.2 1,024 104 10.2 2,742 356 13.0 40,529 3,928 9.7 23,721 1,847 7.8 19,222 1,832 9.5

202021 6 84,735 7,295 8.6 1,132 123 10.9 2,702 346 12.8 37,668 3,347 8.9 21,012 1,506 7.2 18,721 1,699 9.1

202022 6 45,750 3,182 7.0 563 53 9.4 1,446 173 12.0 19,965 1,426 7.1 10,997 708 6.4 10,997 709 6.4

Total 530,878 80,693 15.2 6,029 722 12.0 15,417 2,563 16.6 245,609 37,263 15.2 133,956 19,161 14.3 103,634 16,623 16.0


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos



Spec Tested # Pos

% Pos

202014 6 134,896 66,748 49.5 1,417 332 23.4 3,130 1,117 35.7 71,246 32,709 45.9 35,718 18,959 53.1 17,639 10,758 61.0

202015 6 142,501 62,919 44.2 1,426 355 24.9 3,881 1,310 33.8 74,304 30,508 41.1 38,865 18,151 46.7 17,851 9,840 55.1

202016 6 133,852 47,067 35.2 1,259 239 19.0 4,447 1,215 27.3 66,490 21,982 33.1 35,689 12,950 36.3 17,053 7,275 42.7

202017 6 143,990 39,253 27.3 1,234 149 12.1 4,717 1,145 24.3 70,092 18,596 26.5 39,075 10,716 27.4 22,375 6,920 30.9

202018 6 155,312 30,828 19.8 1,448 172 11.9 5,298 1,041 19.6 74,001 14,860 20.1 41,782 8,086 19.4 25,919 5,301 20.5

202019 6 160,651 22,105 13.8 1,433 149 10.4 5,452 789 14.5 74,025 10,276 13.9 42,971 5,636 13.1 29,786 4,296 14.4

202020 6 208,040 19,097 9.2 1,859 132 7.1 7,598 761 10.0 95,198 8,953 9.4 54,826 4,721 8.6 39,391 3,734 9.5

202021 6 344,758 16,671 4.8 2,307 113 4.9 8,668 550 6.3 162,130 7,688 4.7 93,006 4,174 4.5 59,324 3,376 5.7

202022 6 233,574 7,523 3.2 1,441 49 3.4 4,497 273 6.1 111,315 3,337 3.0 65,300 1,907 2.9 38,955 1,589 4.1

Total 1,657,574 312,211 18.8 13,824 1,690 12.2 47,688 8,201 17.2 798,801 148,909 18.6 447,232 85,300 19.1 268,293 53,089 19.8



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos



Spec Tested # Pos

% Pos

202014 6 56,117 10,628 18.9 922 32 3.5 1,283 147 11.5 30,586 5,419 17.7 13,647 3,002 22.0 7,301 1,580 21.6

202015 6 50,699 10,865 21.4 749 48 6.4 1,131 179 15.8 26,623 5,397 20.3 12,609 2,925 23.2 7,290 1,797 24.7

202016 6 50,553 11,510 22.8 701 79 11.3 1,186 209 17.6 24,533 5,557 22.7 11,547 2,636 22.8 7,639 1,938 25.4

202017 6 77,404 12,698 16.4 914 124 13.6 1,725 394 22.8 38,058 6,653 17.5 18,413 2,836 15.4 15,282 2,218 14.5

202018 6 82,376 14,272 17.3 1,114 180 16.2 2,362 528 22.4 42,138 7,798 18.5 18,935 2,991 15.8 14,150 2,208 15.6

202019 6 92,591 13,485 14.6 1,376 227 16.5 2,837 653 23.0 46,915 7,658 16.3 21,935 2,637 12.0 15,593 1,745 11.2

202020 6 117,827 13,562 11.5 1,733 240 13.8 3,690 702 19.0 56,168 7,746 13.8 27,980 2,548 9.1 23,176 1,751 7.6

202021 6 142,168 14,041 9.9 1,866 230 12.3 4,725 838 17.7 71,307 8,182 11.5 31,951 2,565 8.0 25,565 1,508 5.9

202022 6 90,383 7,277 8.1 1,217 109 9.0 3,086 444 14.4 43,359 4,111 9.5 20,472 1,361 6.6 18,020 931 5.2

Total 760,118 108,338 14.3 10,592 1,269 12.0 22,025 4,094 18.6 379,687 58,521 15.4 177,489 23,501 13.2 134,016 15,676 11.7


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos


202014 6 94,518 10,249 10.8 1,430 35 2.4 2,169 96 4.4 49,570 4,819 9.7 22,479 2,831 12.6 14,646 1,976 13.5

202015 6 80,373 8,162 10.2 916 37 4.0 1,704 107 6.3 40,096 3,885 9.7 19,678 2,168 11.0 13,410 1,485 11.1

202016 6 98,290 8,717 8.9 1,108 40 3.6 2,667 224 8.4 43,413 4,126 9.5 25,011 2,085 8.3 18,632 1,472 7.9

202017 6 109,609 8,987 8.2 1,353 70 5.2 3,237 231 7.1 48,581 4,522 9.3 28,172 2,156 7.7 23,400 1,639 7.0

202018 6 133,157 9,571 7.2 1,661 81 4.9 3,841 359 9.3 57,613 4,933 8.6 34,247 2,133 6.2 30,028 1,686 5.6

202019 6 159,074 9,178 5.8 1,906 70 3.7 4,552 372 8.2 66,584 4,946 7.4 39,940 1,973 4.9 38,995 1,413 3.6

202020 6 204,492 10,695 5.2 2,739 155 5.7 6,264 645 10.3 83,501 5,528 6.6 49,735 2,035 4.1 53,338 1,908 3.6

202021 6 231,119 13,928 6.0 3,254 246 7.6 8,088 838 10.4 99,533 7,645 7.7 54,554 2,611 4.8 55,740 2,020 3.6

202022 6 130,025 9,307 7.2 2,060 143 6.9 4,944 618 12.5 56,325 5,064 9.0 30,264 1,743 5.8 30,598 1,345 4.4

Total 1,240,657 88,794 7.2 16,427 877 5.3 37,466 3,490 9.3 545,216 45,468 8.3 304,080 19,735 6.5 278,787 14,944 5.4


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 42,126 7,820 18.6 669 8 1.2 791 50 6.3 22,133 3,647 16.5 10,118 2,220 21.9 6,644 1,513 22.8

202015 6 35,555 5,935 16.7 555 7 1.3 649 40 6.2 18,057 2,858 15.8 8,837 1,658 18.8 5,901 1,087 18.4

202016 6 33,974 5,240 15.4 516 28 5.4 734 66 9.0 16,266 2,332 14.3 8,028 1,349 16.8 5,808 1,021 17.6

202017 6 50,436 7,080 14.0 723 39 5.4 1,308 181 13.8 25,130 3,686 14.7 12,640 1,691 13.4 8,604 1,228 14.3

202018 6 71,298 9,993 14.0 1,062 71 6.7 1,999 311 15.6 35,288 5,385 15.3 17,443 2,263 13.0 12,332 1,542 12.5

202019 6 117,138 10,683 9.1 1,701 129 7.6 3,519 499 14.2 55,200 5,856 10.6 29,434 2,258 7.7 21,773 1,463 6.7

202020 6 140,705 10,745 7.6 2,037 150 7.4 4,637 534 11.5 65,212 5,973 9.2 34,119 2,185 6.4 28,192 1,482 5.3

202021 6 149,144 11,444 7.7 2,062 180 8.7 4,785 588 12.3 71,449 6,732 9.4 34,530 2,185 6.3 29,633 1,293 4.4

202022 6 99,234 5,964 6.0 1,525 89 5.8 3,506 344 9.8 44,563 3,342 7.5 22,618 1,183 5.2 22,466 755 3.4

Total 739,610 74,904 10.1 10,850 701 6.5 21,928 2,613 11.9 353,298 39,811 11.3 177,767 16,992 9.6 141,353 11,384 8.1



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 62,937 8,585 13.6 1,343 42 3.1 1,989 130 6.5 35,134 4,369 12.4 13,420 2,297 17.1 7,282 1,190 16.3

202015 6 56,563 6,581 11.6 1,102 54 4.9 1,788 165 9.2 30,778 3,371 11.0 12,098 1,628 13.5 7,005 946 13.5

202016 6 63,204 6,567 10.4 1,041 63 6.1 2,140 194 9.1 32,120 3,501 10.9 13,790 1,487 10.8 8,915 822 9.2

202017 6 74,145 7,418 10.0 1,280 89 7.0 3,007 301 10.0 37,512 4,165 11.1 16,220 1,597 9.8 11,089 776 7.0

202018 6 90,491 7,674 8.5 1,622 106 6.5 3,633 388 10.7 43,828 4,279 9.8 19,826 1,577 8.0 14,815 852 5.8

202019 6 101,956 7,995 7.8 1,989 116 5.8 4,096 359 8.8 47,692 4,598 9.6 21,944 1,607 7.3 18,414 829 4.5

202020 6 117,641 8,050 6.8 2,406 151 6.3 5,027 488 9.7 54,552 4,561 8.4 25,037 1,513 6.0 21,814 787 3.6

202021 6 147,408 8,960 6.1 2,807 160 5.7 5,910 608 10.3 69,634 5,129 7.4 30,811 1,632 5.3 28,563 879 3.1

202022 6 62,434 4,528 7.3 1,274 96 7.5 2,985 314 10.5 28,778 2,570 8.9 13,329 833 6.2 13,084 492 3.8

Total 776,779 66,358 8.5 14,864 877 5.9 30,575 2,947 9.6 380,028 36,543 9.6 166,475 14,171 8.5 130,981 7,573 5.8


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 12,538 1,389 11.1 291 6 2.1 358 17 4.7 6,693 633 9.5 2,947 436 14.8 1,727 240 13.9

202015 5 10,463 1,032 9.9 197 2 1.0 310 12 3.9 5,543 546 9.9 2,456 293 11.9 1,493 145 9.7

202016 6 11,187 1,527 13.6 212 4 1.9 289 26 9.0 5,450 783 14.4 2,328 344 14.8 1,511 206 13.6

202017 5 16,447 3,046 18.5 314 31 9.9 638 106 16.6 8,728 1,715 19.6 3,723 768 20.6 2,343 304 13.0

202018 6 24,978 3,301 13.2 429 38 8.9 994 174 17.5 12,271 1,891 15.4 5,935 767 12.9 4,144 292 7.0

202019 6 27,490 2,403 8.7 492 31 6.3 1,071 117 10.9 13,058 1,360 10.4 6,250 481 7.7 5,159 282 5.5

202020 6 34,029 2,164 6.4 657 32 4.9 1,261 130 10.3 15,527 1,256 8.1 8,128 427 5.3 6,905 231 3.3

202021 6 32,362 2,171 6.7 651 45 6.9 1,364 154 11.3 14,811 1,251 8.4 6,971 343 4.9 7,164 272 3.8

202022 6 19,907 1,006 5.1 373 25 6.7 815 87 10.7 8,034 549 6.8 4,674 172 3.7 5,147 124 2.4

Total 189,401 18,039 9.5 3,616 214 5.9 7,100 823 11.6 90,115 9,984 11.1 43,412 4,031 9.3 35,593 2,096 5.9


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 20,153 1,986 9.9 499 13 2.6 850 34 4.0 12,239 1,135 9.3 3,691 449 12.2 2,063 280 13.6

202015 6 12,899 1,510 11.7 289 9 3.1 500 30 6.0 7,223 803 11.1 2,461 340 13.8 1,817 270 14.9

202016 6 11,037 1,021 9.3 194 8 4.1 481 15 3.1 5,779 533 9.2 2,149 201 9.4 1,367 111 8.1

202017 6 13,781 1,378 10.0 272 14 5.1 666 53 8.0 7,340 809 11.0 2,986 288 9.6 1,796 123 6.8

202018 6 15,779 1,460 9.3 352 17 4.8 847 68 8.0 8,054 822 10.2 3,284 281 8.6 2,369 193 8.1

202019 6 23,133 2,198 9.5 520 28 5.4 1,635 184 11.3 11,683 1,246 10.7 4,575 409 8.9 3,522 185 5.3

202020 6 22,449 1,665 7.4 512 22 4.3 1,178 96 8.1 10,950 918 8.4 4,565 287 6.3 3,839 154 4.0

202021 6 25,023 1,435 5.7 480 18 3.8 1,204 90 7.5 11,861 815 6.9 5,144 235 4.6 4,781 108 2.3

202022 6 14,469 502 3.5 232 12 5.2 531 37 7.0 6,683 291 4.4 3,007 83 2.8 3,198 53 1.7

Total 158,723 13,155 8.3 3,350 141 4.2 7,892 607 7.7 81,812 7,372 9.0 31,862 2,573 8.1 24,752 1,477 6.0



Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 56,832 5,941 10.5 864 22 2.5 1,476 87 5.9 29,318 2,741 9.3 12,983 1,576 12.1 9,702 1,271 13.1

202015 6 52,709 5,494 10.4 773 38 4.9 1,496 102 6.8 26,566 2,494 9.4 12,274 1,294 10.5 9,398 1,333 14.2

202016 6 51,872 5,679 10.9 690 40 5.8 1,618 139 8.6 24,102 2,536 10.5 11,583 1,276 11.0 9,754 1,286 13.2

202017 6 62,593 6,085 9.7 862 64 7.4 2,327 224 9.6 28,260 2,892 10.2 14,701 1,308 8.9 13,861 1,362 9.8

202018 6 89,030 7,388 8.3 1,225 68 5.6 3,160 307 9.7 40,329 3,613 9.0 20,781 1,629 7.8 19,820 1,482 7.5

202019 6 104,695 7,483 7.1 1,721 88 5.1 4,294 428 10.0 46,353 3,711 8.0 24,113 1,522 6.3 23,791 1,414 5.9

202020 6 137,583 8,211 6.0 2,136 142 6.6 5,512 512 9.3 63,507 4,318 6.8 31,944 1,645 5.1 28,601 1,234 4.3

202021 6 136,966 8,964 6.5 2,097 154 7.3 5,848 648 11.1 64,280 4,881 7.6 30,430 1,735 5.7 28,114 1,135 4.0

202022 6 82,025 6,642 8.1 1,135 95 8.4 3,446 394 11.4 39,586 3,886 9.8 17,586 1,250 7.1 16,421 753 4.6

Total 774,305 61,887 8.0 11,503 711 6.2 29,177 2,841 9.7 362,301 31,072 8.6 176,395 13,235 7.5 159,462 11,270 7.1


Week No. of

Labs


Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202014 6 19,127 1,362 7.1 399 5 1.3 645 31 4.8 10,779 703 6.5 4,254 362 8.5 2,315 199 8.6

202015 6 17,556 1,240 7.1 302 7 2.3 524 26 5.0 9,582 625 6.5 4,012 307 7.7 2,432 205 8.4

202016 6 12,808 1,002 7.8 233 4 1.7 466 40 8.6 6,644 503 7.6 2,865 253 8.8 1,887 148 7.8

202017 6 14,359 1,038 7.2 242 8 3.3 474 22 4.6 7,437 594 8.0 3,231 243 7.5 2,390 129 5.4

202018 6 14,343 988 6.9 268 8 3.0 557 56 10.1 7,243 586 8.1 3,134 177 5.6 2,556 121 4.7

202019 6 15,791 920 5.8 288 13 4.5 582 46 7.9 7,780 542 7.0 3,456 187 5.4 3,045 99 3.3

202020 6 17,696 946 5.3 416 23 5.5 717 67 9.3 8,341 549 6.6 3,943 185 4.7 3,506 85 2.4

202021 6 17,024 932 5.5 360 23 6.4 737 66 9.0 7,940 569 7.2 3,732 169 4.5 3,538 70 2.0

202022 6 12,549 737 5.9 223 16 7.2 526 37 7.0 5,732 432 7.5 2,721 151 5.5 2,823 75 2.7

Total 141,253 9,165 6.5 2,731 107 3.9 5,228 391 7.5 71,478 5,103 7.1 31,348 2,034 6.5 24,492 1,131 4.6


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet): Overall Percentage of Visits for ILI September 29, 2019 - May 30, 2020


National (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 2,911 6,219 7,658 4,828 1,764 1,449 21,918 1,458,042 1.5 1.5 201941 2,942 6,552 7,637 5,150 2,015 1,604 22,958 1,436,493 1.6 1.6 201942 2,966 7,289 8,296 5,549 2,111 1,651 24,896 1,430,698 1.7 1.7 201943 2,997 7,893 9,354 6,082 2,305 1,794 27,428 1,473,576 1.9 1.8 201944 3,006 8,660 10,076 6,145 2,279 1,764 28,924 1,435,769 2.0 2.0 201945 3,021 10,559 12,555 7,180 2,453 1,843 34,590 1,462,807 2.4 2.4 201946 2,989 11,448 13,676 7,909 2,740 1,970 37,743 1,426,570 2.6 2.6 201947 2,985 12,716 17,056 9,138 3,100 2,148 44,158 1,484,729 3.0 2.9 201948 2,993 14,446 14,821 9,209 3,199 2,372 44,047 1,275,480 3.5 3.4 201949 2,995 13,857 16,400 11,948 3,929 2,780 48,914 1,476,092 3.3 3.3 201950 2,957 14,732 21,883 12,824 4,115 2,905 56,459 1,458,418 3.9 3.9 201951 2,925 18,005 29,186 16,232 4,835 3,349 71,607 1,424,103 5.0 5.1 201952 2,916 24,101 34,003 24,618 7,637 5,407 95,766 1,338,744 7.2 7.1 202001 2,964 21,627 23,413 27,646 9,207 6,876 88,769 1,425,315 6.2 5.9 202002 2,994 15,535 22,697 23,594 8,180 5,460 75,466 1,487,643 5.1 4.9 202003 2,984 16,527 29,598 21,393 7,366 4,727 79,611 1,483,588 5.4 5.3 202004 2,986 18,565 35,221 23,618 7,953 4,662 90,019 1,492,810 6.0 6.1 202005 2,983 20,271 44,039 28,837 9,509 5,472 108,128 1,571,760 6.9 6.7 202006 2,992 20,220 45,471 29,793 10,032 5,693 111,209 1,567,189 7.1 6.8 202007 2,955 17,350 36,849 26,387 9,202 5,448 95,236 1,529,394 6.2 6.1 202008 2,970 15,292 28,480 23,151 8,301 5,176 80,400 1,429,120 5.6 5.5 202009 2,926 13,756 25,376 22,043 8,248 5,101 74,524 1,457,337 5.1 5.1 202010 2,895 13,847 26,357 23,853 8,865 5,691 78,613 1,482,572 5.3 5.3 202011 2,822 14,105 27,702 29,632 11,313 6,693 89,445 1,416,855 6.3 5.7 202012 2,782 10,743 17,477 30,773 12,460 6,977 78,430 1,063,840 7.4 6.4 202013 2,706 5,105 8,283 22,374 10,814 6,450 53,026 848,752 6.2 4.9 202014 2,659 2,354 4,839 14,894 8,673 5,367 36,127 744,181 4.9 3.8 202015 2,656 1,456 3,374 9,933 6,011 4,000 24,774 710,633 3.5 2.8 202016 2,633 1,028 2,604 7,378 4,155 2,900 18,065 700,642 2.6 2.1 202017 2,609 890 2,269 6,294 3,259 2,275 14,987 740,350 2.0 1.7 202018 2,570 847 2,077 5,248 2,651 1,876 12,699 779,352 1.6 1.4 202019 2,516 701 1,852 4,499 2,193 1,592 10,837 792,404 1.4 1.2 202020 2,488 773 1,937 4,065 2,120 1,409 10,304 829,273 1.2 1.1 202021 2,745 869 2,179 4,329 2,107 1,564 11,048 1,027,071 1.1 1.0 202022 2,633 759 1,818 3,446 1,783 1,374 9,180 1,041,245 .9 .9

Totals 1,810,305 44,202,847


HHS Region 1 (CT, ME, MA, NH, RI, and VT) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 255 247 404 324 174 112 1,261 130,089 1.0 .9 201941 261 274 441 396 178 176 1,465 130,676 1.1 1.0 201942 265 313 501 436 179 163 1,592 129,402 1.2 1.1 201943 262 318 513 400 187 153 1,571 133,141 1.2 1.1 201944 271 333 570 389 187 164 1,643 132,506 1.2 1.1 201945 263 390 662 456 162 140 1,810 131,409 1.4 1.3 201946 261 463 681 470 197 136 1,947 127,939 1.5 1.4 201947 264 537 744 515 227 153 2,176 131,725 1.7 1.5 201948 263 621 700 497 216 191 2,225 111,608 2.0 1.8 201949 264 604 742 633 268 225 2,472 124,372 2.0 1.8 201950 263 631 881 630 269 218 2,629 130,387 2.0 1.9 201951 262 844 1,085 819 300 242 3,290 124,306 2.6 2.5 201952 264 946 1,448 1,278 489 402 4,563 115,551 3.9 3.7 202001 263 980 1,378 1,834 675 525 5,392 126,621 4.3 3.9 202002 270 821 1,618 1,707 690 473 5,309 135,907 3.9 3.7 202003 268 976 2,403 1,762 641 427 6,209 132,162 4.7 4.5 202004 265 1,109 3,149 2,156 776 446 7,636 134,954 5.7 5.3 202005 267 1,253 4,226 2,932 947 593 9,951 146,905 6.8 6.4 202006 266 1,328 4,749 3,147 1,056 610 10,890 143,279 7.6 7.2 202007 265 1,147 3,800 2,836 907 568 9,258 139,224 6.6 6.5 202008 267 989 2,741 2,406 956 597 7,689 129,858 5.9 5.7 202009 259 806 2,027 2,081 852 539 6,305 132,556 4.8 4.6 202010 262 758 1,903 1,921 829 523 5,934 129,286 4.6 4.3 202011 244 678 1,831 2,135 873 644 6,161 115,114 5.4 4.8 202012 243 501 1,057 1,963 919 559 4,999 75,667 6.6 5.9 202013 233 192 461 1,356 751 553 3,313 60,637 5.5 4.8 202014 231 76 319 1,151 688 498 2,732 55,595 4.9 4.4 202015 227 44 227 804 555 397 2,027 54,000 3.8 3.4 202016 233 31 214 776 485 376 1,882 55,066 3.4 3.1 202017 218 15 131 542 338 258 1,284 56,003 2.3 2.1 202018 216 33 150 425 212 215 1,035 57,911 1.8 1.7 202019 216 25 127 366 211 164 893 62,492 1.4 1.3 202020 216 33 127 338 220 129 847 64,374 1.3 1.2 202021 218 19 108 260 173 127 687 73,716 .9 .9 202022 208 25 97 220 108 103 553 74,498 .7 .7

Totals 129,630 3,808,936


HHS Region 2 (NJ, NY, PR, and USVI) (Baseline: 3.2%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 263 945 884 642 242 281 2,994 195,431 1.5 2.1 201941 263 969 833 651 284 244 2,981 191,446 1.6 2.1 201942 264 1,187 919 675 313 266 3,360 190,590 1.8 2.4 201943 264 1,133 966 687 306 279 3,371 196,090 1.7 2.0 201944 263 1,368 1,050 700 294 285 3,697 190,727 1.9 2.3 201945 268 1,656 1,197 731 317 294 4,195 193,040 2.2 2.4 201946 259 1,739 1,214 776 362 300 4,391 189,305 2.3 2.7 201947 263 1,775 1,360 874 408 284 4,701 197,786 2.4 2.7 201948 265 2,194 1,513 924 428 311 5,370 178,473 3.0 3.3 201949 264 2,260 1,743 1,134 469 381 5,987 193,324 3.1 3.2 201950 260 2,403 2,456 1,397 517 372 7,145 198,649 3.6 3.7 201951 265 2,791 3,466 1,644 645 452 8,998 195,553 4.6 4.8 201952 256 3,543 4,398 2,823 998 733 12,495 190,159 6.6 6.7 202001 258 3,620 3,439 3,653 1,309 994 13,015 197,051 6.6 6.8 202002 260 2,670 3,356 3,284 1,192 826 11,328 192,914 5.9 6.2 202003 263 2,993 4,911 3,057 1,167 775 12,903 198,476 6.5 6.8 202004 258 3,487 6,026 3,476 1,270 813 15,072 205,644 7.3 7.6 202005 262 3,391 6,742 3,856 1,288 844 16,121 210,325 7.7 7.8 202006 268 3,225 6,823 3,516 1,290 829 15,683 210,836 7.4 7.9 202007 255 2,687 5,076 2,817 1,072 724 12,376 196,848 6.3 6.8 202008 256 2,203 3,120 2,445 917 656 9,341 181,354 5.2 5.9 202009 254 1,828 2,456 2,107 781 596 7,768 183,124 4.2 5.0 202010 255 1,893 2,850 2,586 1,010 651 8,990 180,995 5.0 5.5 202011 251 2,094 4,028 4,572 1,912 1,036 13,642 189,120 7.2 7.6 202012 238 1,395 2,592 7,383 3,267 1,840 16,477 148,939 11.1 11.2 202013 220 604 1,402 7,459 4,371 2,408 16,244 128,503 12.6 11.9 202014 235 257 805 5,228 3,938 2,254 12,482 116,798 10.7 10.5 202015 238 159 549 2,806 2,393 1,611 7,518 100,380 7.5 7.8 202016 242 91 354 1,690 1,350 988 4,473 90,899 4.9 5.2 202017 237 88 281 1,087 737 593 2,786 90,377 3.1 3.5 202018 233 88 227 715 542 392 1,964 92,750 2.1 2.5 202019 231 68 175 466 310 289 1,308 89,316 1.5 1.9 202020 235 112 201 419 291 237 1,260 99,741 1.3 1.8 202021 196 80 141 318 234 174 947 95,634 1.0 1.4 202022 164 89 120 252 167 148 776 96,956 .8 1.3

Totals 272,159 5,797,553


HHS Region 3 (DE, DC, MD, PA, VA, and WV) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 416 797 1,055 754 267 182 3,055 234,770 1.3 1.2 201941 423 874 1,137 844 331 250 3,436 237,191 1.4 1.3 201942 418 986 1,118 842 338 270 3,554 227,164 1.6 1.4 201943 431 1,079 1,322 1,044 382 256 4,083 239,162 1.7 1.6 201944 421 1,133 1,338 929 350 251 4,001 234,242 1.7 1.5 201945 429 1,265 1,405 1,069 391 249 4,379 234,584 1.9 1.7 201946 420 1,362 1,630 1,158 415 268 4,833 230,308 2.1 1.9 201947 423 1,567 1,931 1,251 516 298 5,563 241,623 2.3 2.1 201948 421 1,858 1,887 1,346 480 345 5,916 212,108 2.8 2.4 201949 414 1,584 2,155 1,780 549 394 6,462 235,580 2.7 2.4 201950 421 1,960 3,221 2,086 632 453 8,352 238,415 3.5 3.0 201951 421 2,378 4,726 2,728 774 541 11,147 241,177 4.6 3.9 201952 423 3,347 5,743 4,101 1,211 878 15,280 230,061 6.6 5.6 202001 421 3,240 4,229 5,062 1,565 1,190 15,286 247,495 6.2 5.5 202002 424 2,233 3,595 4,047 1,311 901 12,087 247,105 4.9 4.4 202003 426 2,259 4,403 3,677 1,194 764 12,297 245,508 5.0 4.6 202004 420 2,485 5,202 4,099 1,396 735 13,917 239,344 5.8 5.3 202005 425 2,774 6,891 5,385 1,748 872 17,670 256,167 6.9 6.3 202006 424 2,740 7,200 5,763 1,938 1,053 18,694 257,695 7.3 6.5 202007 423 2,593 6,348 5,466 1,889 1,057 17,353 272,338 6.4 5.8 202008 426 2,277 4,986 4,674 1,710 891 14,538 246,032 5.9 5.3 202009 420 2,126 4,702 4,671 1,706 921 14,126 248,312 5.7 5.2 202010 417 2,069 4,777 4,944 1,835 1,102 14,727 262,206 5.6 5.1 202011 416 2,287 4,976 6,065 2,380 1,251 16,959 256,511 6.6 6.1 202012 416 1,788 3,065 5,201 2,077 1,117 13,248 189,566 7.0 6.8 202013 411 886 1,297 3,147 1,404 794 7,528 148,795 5.1 4.9 202014 392 370 800 2,097 1,071 673 5,011 129,753 3.9 3.8 202015 385 270 535 1,750 834 524 3,913 125,094 3.1 3.0 202016 374 159 452 1,467 681 419 3,178 121,390 2.6 2.4 202017 402 129 420 1,440 639 362 2,990 135,525 2.2 2.0 202018 393 121 388 1,386 594 354 2,843 142,430 2.0 1.8 202019 386 121 360 1,119 524 289 2,413 146,578 1.6 1.4 202020 380 120 349 936 467 258 2,130 152,423 1.4 1.3 202021 368 140 349 846 377 248 1,960 158,469 1.2 1.1 202022 361 77 237 544 308 223 1,389 160,055 .9 .8

Totals 294,318 7,425,176


HHS Region 4 (AL, FL, GA, KY, MS, NC, SC, and TN) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 560 1,783 1,971 1,234 364 284 5,636 333,396 1.7 1.7 201941 557 1,757 1,710 1,219 376 288 5,350 317,589 1.7 1.6 201942 571 1,831 1,871 1,338 397 303 5,740 312,547 1.8 1.8 201943 574 2,107 2,211 1,496 507 362 6,683 322,052 2.1 2.0 201944 580 2,300 2,475 1,507 492 345 7,119 318,970 2.2 2.3 201945 584 2,917 3,174 1,906 555 383 8,935 323,507 2.8 2.9 201946 579 3,154 3,432 2,072 677 422 9,757 312,438 3.1 3.1 201947 566 3,301 4,481 2,491 708 450 11,431 315,660 3.6 3.3 201948 572 4,046 4,299 2,617 847 597 12,406 294,185 4.2 4.2 201949 578 3,828 4,646 3,486 1,046 693 13,699 331,928 4.1 4.0 201950 575 3,945 6,626 3,925 1,168 683 16,347 327,859 5.0 5.0 201951 553 5,243 9,285 5,352 1,453 850 22,183 323,870 6.8 6.4 201952 558 7,471 10,306 8,313 2,525 1,524 30,139 321,109 9.4 8.8 202001 567 5,901 6,142 8,235 2,700 1,801 24,779 329,997 7.5 6.8 202002 568 3,709 5,425 6,268 2,007 1,185 18,594 328,884 5.7 5.2 202003 569 3,886 7,017 5,380 1,769 997 19,049 327,657 5.8 5.4 202004 576 4,128 7,560 5,596 1,718 911 19,913 323,326 6.2 6.4 202005 566 4,795 10,112 7,334 2,275 1,137 25,653 341,638 7.5 7.5 202006 570 5,062 10,963 7,999 2,457 1,252 27,733 352,234 7.9 7.3 202007 564 3,864 7,870 6,528 2,145 1,150 21,557 333,750 6.5 6.3 202008 574 2,994 5,583 4,947 1,510 907 15,941 285,138 5.6 5.4 202009 566 2,708 5,285 4,989 1,686 953 15,621 311,004 5.0 4.8 202010 560 3,153 6,125 5,448 1,869 1,027 17,622 325,409 5.4 5.4 202011 538 3,245 6,535 6,758 2,352 1,349 20,239 315,593 6.4 5.8 202012 535 2,776 4,190 6,472 2,408 1,244 17,090 249,146 6.9 5.9 202013 532 1,442 2,076 4,064 1,599 989 10,170 196,528 5.2 4.3 202014 516 700 1,170 2,390 957 680 5,897 165,823 3.6 3.1 202015 509 417 786 1,640 770 530 4,143 157,069 2.6 2.0 202016 502 308 577 1,248 567 412 3,112 156,076 2.0 1.6 202017 488 259 490 1,078 505 395 2,727 162,065 1.7 1.2 202018 487 214 420 910 452 315 2,311 168,553 1.4 1.0 202019 488 197 394 920 383 330 2,224 182,852 1.2 .8 202020 483 204 469 845 429 285 2,232 189,933 1.2 .8 202021 808 305 789 1,374 667 598 3,733 352,197 1.1 1.0 202022 792 308 728 1,340 651 478 3,505 360,793 1.0 1.0

Totals 439,270 10,070,775


HHS Region 5 (IL, IN, MI, MN, OH, and WI) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 393 558 741 354 139 124 1,916 162,310 1.2 1.1 201941 398 647 754 400 180 156 2,137 155,532 1.4 1.3 201942 398 736 837 416 189 142 2,320 159,980 1.5 1.3 201943 412 803 894 509 232 157 2,595 170,600 1.5 1.4 201944 411 796 927 510 197 150 2,580 166,324 1.6 1.4 201945 417 859 974 519 215 165 2,732 170,288 1.6 1.5 201946 418 872 906 546 208 188 2,720 164,128 1.7 1.5 201947 416 935 1,126 545 228 178 3,012 169,491 1.8 1.6 201948 418 1,182 1,016 509 208 173 3,088 146,700 2.1 2.0 201949 419 1,329 1,312 727 281 205 3,854 175,439 2.2 2.1 201950 412 1,466 1,588 740 272 209 4,275 165,201 2.6 2.4 201951 415 1,732 2,043 942 322 231 5,270 154,007 3.4 3.2 201952 410 2,161 2,382 1,390 427 327 6,687 133,670 5.0 4.8 202001 412 2,144 1,725 1,591 526 424 6,410 154,720 4.1 3.5 202002 414 1,615 1,813 1,440 534 347 5,749 165,401 3.5 2.9 202003 414 1,614 2,371 1,275 453 271 5,984 165,616 3.6 3.1 202004 419 1,915 3,401 1,670 503 284 7,773 168,294 4.6 4.2 202005 412 2,296 4,504 2,151 674 380 10,005 177,139 5.6 5.0 202006 415 2,280 4,943 2,442 820 415 10,900 177,314 6.1 5.5 202007 411 2,021 4,150 2,296 745 403 9,615 168,282 5.7 5.3 202008 404 1,846 3,550 2,349 773 447 8,965 169,280 5.3 4.7 202009 401 1,620 3,059 2,028 780 516 8,003 164,853 4.9 4.5 202010 405 1,522 2,837 2,251 837 586 8,033 169,943 4.7 4.3 202011 389 1,478 2,718 2,611 872 542 8,221 149,985 5.5 4.6 202012 391 1,146 1,742 2,432 936 463 6,719 110,732 6.1 4.6 202013 372 464 665 1,523 615 313 3,580 81,062 4.4 3.1 202014 365 213 397 1,028 504 232 2,374 72,359 3.3 2.2 202015 374 127 311 839 435 212 1,924 77,768 2.5 1.8 202016 370 90 273 721 383 170 1,637 78,554 2.1 1.5 202017 368 102 280 742 373 171 1,668 87,978 1.9 1.5 202018 358 95 273 718 330 152 1,568 90,913 1.7 1.5 202019 309 72 251 613 272 133 1,341 82,090 1.6 1.2 202020 304 89 289 621 233 117 1,349 84,436 1.6 1.3 202021 282 78 253 592 209 91 1,223 86,975 1.4 .9 202022 277 43 127 276 141 98 685 89,711 .8 .6

Totals 156,912 4,867,075


HHS Region 6 (AR, LA, NM, OK, and TX) (Baseline: 3.8%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 309 1,110 1,249 671 217 140 3,387 122,699 2.8 2.2 201941 307 1,184 1,327 739 228 155 3,633 121,390 3.0 2.5 201942 311 1,193 1,488 863 260 151 3,955 121,617 3.3 2.7 201943 313 1,392 1,801 980 255 185 4,613 122,600 3.8 3.2 201944 315 1,616 2,151 1,157 332 207 5,463 120,455 4.5 3.7 201945 316 2,087 3,119 1,458 368 222 7,254 127,147 5.7 4.7 201946 306 2,346 3,491 1,739 396 243 8,215 125,373 6.6 5.0 201947 309 2,752 4,632 2,136 515 325 10,360 133,630 7.8 6.3 201948 309 2,625 3,147 2,018 518 315 8,623 108,631 7.9 6.9 201949 304 2,059 2,834 2,234 598 349 8,074 125,317 6.4 5.8 201950 283 2,022 3,209 1,883 488 326 7,928 112,757 7.0 7.7 201951 276 2,226 3,774 2,045 525 340 8,910 106,476 8.4 10.1 201952 273 3,032 4,163 3,066 827 569 11,657 104,199 11.2 13.5 202001 297 2,391 2,796 3,434 1,070 746 10,437 112,117 9.3 10.0 202002 308 1,868 2,933 3,282 1,079 576 9,738 121,644 8.0 8.8 202003 305 2,107 3,774 3,098 955 528 10,462 122,544 8.5 9.7 202004 308 2,300 4,306 3,115 974 514 11,209 124,949 9.0 9.9 202005 309 2,532 5,163 3,626 1,170 611 13,102 130,917 10.0 10.7 202006 308 2,381 4,697 3,339 1,084 530 12,031 119,456 10.1 10.3 202007 303 2,164 4,303 3,318 1,101 538 11,424 123,799 9.2 9.4 202008 304 2,076 3,864 3,174 1,070 602 10,786 124,635 8.7 8.7 202009 297 2,092 3,405 2,961 1,012 546 10,016 120,902 8.3 8.0 202010 295 1,851 3,267 3,105 1,036 638 9,897 124,400 8.0 7.8 202011 291 1,843 3,086 3,228 1,191 692 10,040 117,945 8.5 7.2 202012 279 1,371 2,298 3,538 1,387 771 9,365 96,575 9.7 8.3 202013 276 726 1,087 2,409 1,057 669 5,948 72,126 8.2 5.7 202014 267 340 585 1,448 727 505 3,605 59,728 6.0 4.2 202015 273 211 434 950 441 381 2,417 57,668 4.2 3.2 202016 269 160 337 684 317 236 1,734 55,232 3.1 2.3 202017 262 164 291 652 275 208 1,590 57,479 2.8 2.2 202018 253 127 242 493 228 186 1,276 59,918 2.1 1.6 202019 262 118 240 453 207 151 1,169 62,628 1.9 1.4 202020 257 118 201 410 202 165 1,096 65,970 1.7 1.3 202021 286 143 217 425 205 142 1,132 79,300 1.4 1.2 202022 261 110 222 347 185 138 1,002 76,557 1.3 1.2

Totals 241,548 3,638,780


HHS Region 7 (IA, KS, MO, and NE) (Baseline: 1.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 130 109 166 72 25 16 388 36,003 1.1 .8 201941 132 129 189 73 32 26 449 35,517 1.3 .8 201942 130 174 237 93 26 23 553 37,930 1.5 1.0 201943 132 174 242 87 37 30 570 38,236 1.5 1.1 201944 132 176 212 83 40 32 543 35,531 1.5 1.2 201945 132 180 246 107 35 34 602 37,506 1.6 1.2 201946 132 257 261 109 47 30 704 36,610 1.9 1.7 201947 132 307 315 93 37 32 784 38,745 2.0 1.5 201948 130 402 261 130 65 51 909 29,265 3.1 1.7 201949 133 405 351 223 70 43 1,092 38,718 2.8 1.8 201950 133 452 502 273 85 53 1,365 37,677 3.6 2.2 201951 132 455 687 301 91 65 1,599 35,002 4.6 2.8 201952 129 677 870 525 153 102 2,327 28,680 8.1 5.6 202001 130 616 613 598 187 146 2,160 31,432 6.9 4.8 202002 129 457 566 528 186 114 1,851 33,939 5.5 3.6 202003 129 443 790 404 112 87 1,836 33,324 5.5 5.3 202004 129 412 848 411 125 62 1,858 34,151 5.4 6.1 202005 128 430 1,097 418 144 81 2,170 35,795 6.1 6.9 202006 129 456 1,231 471 127 107 2,392 36,735 6.5 7.3 202007 128 437 1,039 497 188 124 2,285 35,478 6.4 6.4 202008 129 449 942 481 182 113 2,167 36,125 6.0 5.9 202009 127 396 767 388 185 121 1,857 33,287 5.6 6.7 202010 126 411 798 395 149 133 1,886 34,946 5.4 7.0 202011 123 394 635 492 179 119 1,819 32,103 5.7 6.5 202012 120 328 368 531 194 95 1,516 24,793 6.1 5.9 202013 117 144 185 318 136 75 858 19,738 4.3 3.7 202014 117 48 102 216 98 69 533 17,283 3.1 2.0 202015 117 26 59 152 64 44 345 16,019 2.2 1.4 202016 114 33 44 108 36 29 250 16,007 1.6 1.0 202017 114 11 48 103 43 39 244 17,368 1.4 .8 202018 112 25 44 87 32 30 218 18,476 1.2 1.0 202019 107 8 28 76 33 26 171 18,680 .9 .5 202020 106 15 34 67 44 11 171 19,281 .9 .5 202021 100 13 26 59 22 21 141 19,329 .7 .4 202022 96 10 21 55 25 19 130 16,437 .8 .5

Totals 38,743 1,046,146


HHS Region 8 (CO, MT, ND, SD, UT, and WY) (Baseline: 2.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 223 325 525 369 132 113 1,464 89,062 1.6 1.8 201941 229 332 511 380 162 120 1,505 94,226 1.6 1.8 201942 232 427 513 416 167 132 1,655 98,201 1.7 1.9 201943 231 402 554 430 166 164 1,716 96,380 1.8 2.0 201944 232 382 485 398 169 131 1,565 86,690 1.8 2.0 201945 227 511 603 392 146 122 1,774 93,003 1.9 2.1 201946 228 496 662 416 176 140 1,890 85,341 2.2 2.4 201947 228 603 775 465 170 149 2,162 89,171 2.4 2.6 201948 228 684 682 469 158 130 2,123 70,708 3.0 3.2 201949 230 676 790 567 210 159 2,402 86,046 2.8 3.0 201950 224 651 1,055 658 229 200 2,793 83,098 3.4 3.6 201951 223 893 1,368 793 248 232 3,534 86,211 4.1 4.4 201952 229 1,062 1,673 1,217 401 328 4,681 78,163 6.0 6.3 202001 227 1,054 1,200 1,176 434 367 4,231 77,108 5.5 5.8 202002 228 959 1,371 1,226 394 373 4,323 86,878 5.0 5.2 202003 223 1,030 1,711 1,161 389 342 4,633 86,732 5.3 5.6 202004 222 1,279 2,079 1,402 476 320 5,556 88,887 6.3 6.5 202005 224 1,318 2,429 1,463 529 363 6,102 92,522 6.6 6.8 202006 225 1,209 2,178 1,470 525 345 5,727 89,352 6.4 6.7 202007 221 1,058 1,740 1,179 477 355 4,809 86,262 5.6 5.9 202008 225 1,030 1,541 1,141 434 331 4,477 84,564 5.3 5.5 202009 224 909 1,432 1,163 480 323 4,307 89,104 4.8 5.0 202010 211 894 1,445 1,277 485 387 4,488 87,220 5.1 5.2 202011 215 852 1,645 1,647 645 377 5,166 84,775 6.1 6.3 202012 215 534 826 1,315 461 315 3,451 58,589 5.9 6.2 202013 208 238 372 727 273 190 1,800 48,114 3.7 4.0 202014 210 130 241 489 227 115 1,202 44,122 2.7 2.9 202015 208 72 181 340 152 84 829 41,647 2.0 2.1 202016 199 51 93 253 96 62 555 43,367 1.3 1.4 202017 199 47 112 221 88 66 534 45,085 1.2 1.2 202018 203 36 87 163 70 48 404 47,344 .9 .9 202019 201 40 92 131 72 44 379 48,386 .8 .8 202020 201 37 91 130 49 41 348 49,860 .7 .7 202021 198 33 87 137 51 32 340 52,187 .7 .6 202022 195 38 87 128 48 39 340 50,940 .7 .6

Totals 93,265 2,619,345


HHS Region 9 (AZ, CA, HI, and NV) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 195 251 436 184 107 98 1,076 82,844 1.3 1.3 201941 194 257 465 211 128 97 1,158 81,621 1.4 1.5 201942 199 282 537 205 137 114 1,275 80,978 1.6 1.6 201943 199 316 571 238 138 129 1,392 84,077 1.7 1.7 201944 200 371 595 265 133 116 1,480 82,073 1.8 1.8 201945 205 499 880 317 163 164 2,023 87,475 2.3 2.3 201946 207 567 1,095 411 179 160 2,412 90,242 2.7 2.6 201947 206 583 1,059 442 182 188 2,454 94,874 2.6 2.5 201948 204 518 762 413 175 165 2,033 67,070 3.0 2.9 201949 208 588 901 617 277 207 2,590 92,045 2.8 2.8 201950 206 568 971 503 236 225 2,503 89,739 2.8 2.8 201951 202 633 956 596 225 224 2,634 84,369 3.1 3.2 201952 204 723 892 670 273 258 2,816 65,035 4.3 4.6 202001 214 776 748 850 377 358 3,109 76,904 4.0 4.6 202002 214 641 1,151 872 442 401 3,507 101,190 3.5 3.8 202003 209 679 1,451 868 414 353 3,765 101,236 3.7 4.1 202004 212 828 1,761 923 432 397 4,341 100,529 4.3 4.7 202005 213 896 1,975 906 435 392 4,604 107,023 4.3 4.7 202006 209 971 1,884 992 452 397 4,696 107,691 4.4 4.8 202007 209 803 1,697 793 390 345 4,028 100,082 4.0 4.5 202008 211 778 1,347 867 471 432 3,895 99,016 3.9 4.3 202009 203 659 1,390 874 412 372 3,707 101,232 3.7 4.0 202010 186 651 1,206 740 314 300 3,211 95,355 3.4 3.7 202011 180 577 1,071 844 375 320 3,187 87,530 3.6 4.0 202012 175 366 560 700 293 234 2,153 55,644 3.9 4.6 202013 171 180 327 555 258 219 1,539 49,738 3.1 3.5 202014 161 103 201 361 193 193 1,051 43,667 2.4 2.6 202015 161 59 129 268 182 115 753 41,804 1.8 2.0 202016 166 46 131 199 134 127 637 44,655 1.4 1.5 202017 158 33 119 177 122 101 552 46,178 1.2 1.3 202018 155 30 104 153 111 104 502 44,880 1.1 1.1 202019 158 26 100 167 98 85 476 53,171 .9 1.0 202020 149 26 88 129 89 108 440 55,430 .8 .8 202021 133 30 130 142 95 84 481 60,880 .8 .8 202022 121 31 96 144 80 72 423 63,598 .7 .7

Totals 76,903 2,719,875


HHS Region 10 (AK, ID, OR, and WA) (Baseline: 1.5%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 166 94 227 223 95 99 738 71,045 1.0 1.0 201941 178 129 270 237 116 92 844 71,305 1.2 1.1 201942 178 160 275 265 105 87 892 72,289 1.2 1.2 201943 179 169 280 211 95 79 834 71,238 1.2 1.1 201944 181 185 273 207 85 83 833 68,251 1.2 1.2 201945 180 195 295 225 101 70 886 64,848 1.4 1.3 201946 179 192 304 212 83 83 874 64,886 1.3 1.4 201947 178 356 633 326 109 91 1,515 72,024 2.1 2.2 201948 183 316 554 286 104 94 1,354 56,732 2.4 2.8 201949 180 524 921 544 161 124 2,274 73,068 3.1 3.3 201950 180 634 1,374 729 219 166 3,122 74,636 4.2 4.5 201951 176 810 1,796 1,012 252 172 4,042 73,132 5.5 5.8 201952 169 1,139 2,127 1,233 331 285 5,115 71,965 7.1 7.2 202001 175 905 1,143 1,213 364 325 3,950 71,870 5.5 5.7 202002 179 562 869 940 345 264 2,980 73,781 4.0 4.1 202003 178 540 767 711 272 183 2,473 70,333 3.5 3.6 202004 177 622 889 770 283 180 2,744 72,732 3.8 3.8 202005 177 586 900 766 299 199 2,750 73,329 3.8 3.9 202006 178 568 803 654 283 155 2,463 72,597 3.4 3.5 202007 176 576 826 657 288 184 2,531 73,331 3.5 3.4 202008 174 650 806 667 278 200 2,601 73,118 3.6 3.6 202009 175 612 853 781 354 214 2,814 72,963 3.9 3.9 202010 178 645 1,149 1,186 501 344 3,825 72,812 5.3 5.6 202011 175 657 1,177 1,280 534 363 4,011 68,179 5.9 5.8 202012 170 538 779 1,238 518 339 3,412 54,189 6.3 5.9 202013 166 229 411 816 350 240 2,046 43,511 4.7 4.3 202014 165 117 219 486 270 148 1,240 39,053 3.2 3.1 202015 164 71 163 384 185 102 905 39,184 2.3 2.1 202016 164 59 129 232 106 81 607 39,396 1.5 1.8 202017 163 42 97 252 139 82 612 42,292 1.4 1.7 202018 160 78 142 198 80 80 578 56,177 1.0 1.2 202019 158 26 85 188 83 81 463 46,211 1.0 1.2 202020 157 19 88 170 96 58 431 47,825 .9 1.1 202021 155 28 79 176 74 47 404 48,155 .8 .6 202022 157 28 83 140 70 56 377 51,546 .7 .9

Totals 67,540 2,208,003


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet): Percentage of Visits for ILI by Age Group Reported by A Subset of ILINet Providers

September 29, 2019 - May 30, 2020 Data as of June 4, 2020

National

Week 0-4 years 5-24 years 25-49 years 50-64 years 65+ years

Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI Total Visits

% ILI

201940 56,425 6.0 172,613 2.4 249,835 1.2 135,200 0.7 150,920 0.5

201941 58,796 6.2 171,544 2.4 247,783 1.3 136,850 0.8 154,875 0.6

201942 59,998 6.8 166,934 2.7 242,650 1.4 135,354 0.9 154,625 0.6

201943 61,136 7.1 176,231 2.9 249,931 1.5 139,369 0.9 158,148 0.6

201944 63,547 7.4 171,729 3.1 245,723 1.5 133,493 0.9 151,858 0.6

201945 66,254 8.4 174,035 3.7 243,311 1.7 133,090 1.0 151,920 0.6

201946 67,301 9.3 170,191 4.2 240,821 2.0 131,489 1.2 148,155 0.7

201947 73,344 9.7 177,139 5.0 253,460 2.2 138,845 1.3 154,044 0.8

201948 74,382 11.1 152,778 5.3 231,731 2.4 127,018 1.4 148,199 0.9

201949 73,293 10.6 175,105 4.9 255,541 2.8 136,885 1.6 155,906 1.0

201950 76,087 10.8 183,535 6.1 254,931 3.0 137,872 1.7 155,624 1.0

201951 81,387 12.4 183,296 8.3 251,896 3.7 135,149 1.9 155,485 1.2

201952 90,324 15.9 170,254 11.5 258,698 5.9 140,840 3.2 165,273 2.0

202001 86,651 14.7 162,694 8.4 279,484 5.9 148,891 3.5 169,551 2.4

202002 72,255 12.3 172,811 7.0 272,768 5.1 146,861 3.1 164,556 1.9

202003 73,290 12.8 183,184 8.1 265,625 4.8 143,089 2.9 159,574 1.7

202004 75,415 13.8 185,850 9.4 265,289 5.3 141,861 3.2 157,292 1.7

202005 78,663 14.6 208,241 10.5 277,043 6.3 144,594 3.9 159,862 2.0

202006 78,330 15.0 207,802 11.2 275,064 6.8 146,129 4.1 158,963 2.1

202007 75,357 13.5 196,432 9.7 273,529 6.1 147,856 3.8 162,299 2.0

202008 68,083 13.1 174,085 8.6 250,155 5.7 136,284 3.8 150,863 2.1

202009 67,797 11.8 179,610 7.4 260,848 5.4 141,819 3.6 157,641 2.0

202010 69,083 11.7 188,285 7.4 270,129 5.5 146,865 3.7 162,075 2.2

202011 66,469 12.4 185,585 8.4 274,943 6.8 144,200 4.9 150,575 2.7

202012 45,640 13.9 118,217 8.6 230,370 7.7 116,231 6.2 109,799 3.7

202013 29,668 10.2 83,589 5.7 194,313 6.4 99,562 5.8 94,747 3.8

202014 21,637 6.2 70,538 4.0 169,577 5.0 90,498 5.2 87,391 3.3

202015 19,759 4.2 67,195 2.9 157,092 3.7 88,250 3.8 88,938 2.5

202016 19,124 3.0 65,433 2.2 150,661 2.9 85,073 2.8 89,731 1.8

202017 20,274 2.4 71,176 1.8 161,155 2.3 91,744 2.1 97,603 1.4

202018 21,241 2.1 77,088 1.6 167,819 1.9 93,900 1.6 101,719 1.1

202019 22,638 1.7 82,070 1.3 175,276 1.5 99,947 1.3 107,409 0.9

202020 23,936 1.8 86,533 1.3 179,404 1.3 100,862 1.2 110,812 0.7

202021 32,154 1.7 118,101 1.1 253,083 1.1 143,289 1.0 160,729 0.7

202022 32,891 1.5 127,014 1.0 260,077 0.9 146,120 0.8 164,286 0.6

Totals 2,002,629 5,256,917 8,290,015 4,505,379 4,971,447


National Syndromic Surveillance Program (NSSP): Emergency Department Visits Percentage of Visits for COVID-19-Like Illness (CLI) or Influenza-like Illness (ILI)

September 29, 2019 - May 30, 2020 Data as of June 4, 2020

National

Week Number of Facilities

Reporting

Total Number of ED Visits

CLI Visits ILI Visits

Number Percent of Total Visits Number Percent of Total

Visits 201940 3,314 2,167,248 23,108 1.1 19,731 0.9

201941 3,310 2,122,018 24,061 1.1 20,604 1.0

201942 3,311 2,116,541 26,447 1.2 22,678 1.1

201943 3,315 2,137,611 27,533 1.3 23,929 1.1

201944 3,354 2,095,690 29,259 1.4 25,627 1.2

201945 3,364 2,144,173 33,912 1.6 30,137 1.4

201946 3,381 2,128,320 36,243 1.7 32,611 1.5

201947 3,397 2,216,182 39,285 1.8 36,248 1.6

201948 3,395 2,104,818 43,052 2.0 39,920 1.9

201949 3,400 2,232,092 41,818 1.9 37,859 1.7

201950 3,411 2,246,003 44,036 2.0 42,641 1.9

201951 3,401 2,229,735 49,684 2.2 51,053 2.3

201952 3,406 2,336,526 64,407 2.8 68,784 2.9

202001 3,432 2,414,095 58,860 2.4 57,771 2.4

202002 3,429 2,298,736 43,490 1.9 42,768 1.9

202003 3,430 2,269,414 42,426 1.9 44,771 2.0

202004 3,453 2,267,045 46,125 2.0 49,768 2.2

202005 3,466 2,359,539 54,112 2.3 59,887 2.5

202006 3,457 2,347,891 53,285 2.3 59,219 2.5

202007 3,477 2,282,138 47,515 2.1 51,089 2.2

202008 3,478 2,267,126 44,134 1.9 46,158 2.0

202009 3,490 2,231,268 40,916 1.8 41,978 1.9

202010 3,502 2,259,189 49,544 2.2 50,044 2.2

202011 3,506 2,244,801 76,871 3.4 71,635 3.2

202012 3,503 1,801,445 107,778 6.0 84,643 4.7

202013 3,516 1,447,276 99,624 6.9 62,494 4.3

202014 3,520 1,261,162 87,160 6.9 43,957 3.5

202015 3,510 1,199,582 72,826 6.1 30,259 2.5

202016 3,515 1,178,197 59,094 5.0 21,420 1.8

202017 3,504 1,247,859 53,171 4.3 17,533 1.4

202018 3,511 1,304,053 48,722 3.7 14,933 1.1

202019 3,509 1,365,821 42,517 3.1 12,617 0.9

202020 3,511 1,414,412 38,598 2.7 11,834 0.8

202021 3,528 1,514,701 35,149 2.3 11,300 0.7

202022 3,555 1,597,335 29,364 1.8 9,905 0.6

Total 68,850,042 1,714,126 1,347,805




Reporting




Visits

201940 203 132,282 1,032 0.8 749 0.6

201941 202 130,412 1,121 0.9 814 0.6

201942 202 132,415 1,208 0.9 912 0.7

201943 202 131,893 1,249 0.9 883 0.7

201944 203 128,280 1,203 0.9 888 0.7

201945 203 127,500 1,365 1.1 979 0.8

201946 202 125,335 1,538 1.2 1,188 0.9

201947 202 128,913 1,547 1.2 1,235 1.0

201948 203 124,822 1,795 1.4 1,452 1.2

201949 203 125,985 1,837 1.5 1,362 1.1

201950 202 130,481 1,789 1.4 1,405 1.1

201951 202 126,353 1,964 1.6 1,704 1.3

201952 203 136,134 2,734 2.0 2,483 1.8

202001 203 144,637 2,903 2.0 2,568 1.8

202002 202 140,156 2,349 1.7 2,192 1.6

202003 202 134,810 2,423 1.8 2,452 1.8

202004 202 139,774 2,732 2.0 2,945 2.1

202005 202 146,377 3,254 2.2 3,497 2.4

202006 202 143,970 3,223 2.2 3,612 2.5

202007 202 138,242 2,729 2.0 2,845 2.1

202008 202 132,295 2,307 1.7 2,291 1.7

202009 202 133,049 2,076 1.6 1,913 1.4

202010 199 129,470 2,376 1.8 2,297 1.8

202011 199 123,652 3,890 3.1 3,320 2.7

202012 199 91,553 5,454 6.0 3,607 3.9

202013 201 74,695 5,522 7.4 2,561 3.4

202014 201 67,577 6,159 9.1 2,123 3.1

202015 196 67,219 6,278 9.3 1,654 2.5

202016 195 66,682 5,990 9.0 1,360 2.0

202017 195 71,284 5,791 8.1 1,041 1.5

202018 195 74,451 4,972 6.7 743 1.0

202019 194 79,081 4,243 5.4 683 0.9

202020 193 81,221 3,581 4.4 612 0.8

202021 193 86,024 2,801 3.3 498 0.6

202022 193 90,708 1,971 2.2 415 0.5

Total 4,037,732 103,406 61,283




Reporting




Visits

201940 196 225,747 2,136 0.9 1,782 0.8

201941 196 221,822 2,056 0.9 1,787 0.8

201942 195 220,012 2,322 1.1 2,002 0.9

201943 195 224,705 2,362 1.1 2,101 0.9

201944 196 220,733 2,708 1.2 2,342 1.1

201945 195 218,950 2,953 1.3 2,642 1.2

201946 196 215,950 3,260 1.5 2,798 1.3

201947 196 225,690 3,423 1.5 3,055 1.4

201948 196 216,728 3,924 1.8 3,626 1.7

201949 196 224,227 4,059 1.8 3,707 1.7

201950 196 230,490 4,329 1.9 4,122 1.8

201951 195 224,964 4,962 2.2 4,924 2.2

201952 195 239,727 6,489 2.7 6,864 2.9

202001 195 250,134 6,478 2.6 6,740 2.7

202002 195 243,446 4,981 2.0 5,342 2.2

202003 195 238,555 5,057 2.1 5,617 2.4

202004 195 238,672 5,614 2.4 6,432 2.7

202005 195 245,398 6,123 2.5 7,050 2.9

202006 195 241,584 5,815 2.4 6,702 2.8

202007 195 228,902 4,643 2.0 5,202 2.3

202008 195 222,235 3,957 1.8 4,219 1.9

202009 195 222,047 3,567 1.6 3,696 1.7

202010 195 222,255 4,795 2.2 5,000 2.2

202011 195 223,512 9,794 4.4 9,203 4.1

202012 195 188,427 17,817 9.5 14,306 7.6

202013 195 166,925 23,396 14.0 15,271 9.1

202014 194 144,642 23,058 15.9 11,752 8.1

202015 195 123,511 17,932 14.5 7,083 5.7

202016 195 110,031 12,338 11.2 4,053 3.7

202017 194 106,993 8,420 7.9 2,286 2.1

202018 195 110,049 6,363 5.8 1,569 1.4

202019 195 114,389 4,569 4.0 1,083 0.9

202020 195 117,667 3,613 3.1 901 0.8

202021 195 125,812 2,748 2.2 798 0.6

202022 195 134,438 2,034 1.5 612 0.5

Total 6,929,369 228,095 166,669




Reporting




Visits

201940 332 233,590 2,038 0.9 1,590 0.7

201941 333 231,163 2,118 0.9 1,619 0.7

201942 333 226,274 2,249 1.0 1,706 0.8

201943 337 231,383 2,295 1.0 1,742 0.8

201944 335 229,707 2,379 1.0 1,814 0.8

201945 335 224,922 2,574 1.1 2,000 0.9

201946 337 225,141 2,830 1.3 2,266 1.0

201947 340 233,869 3,124 1.3 2,451 1.0

201948 340 221,050 3,409 1.5 2,768 1.3

201949 338 233,916 3,361 1.4 2,787 1.2

201950 339 237,396 3,623 1.5 3,138 1.3

201951 341 236,524 4,066 1.7 3,727 1.6

201952 340 250,352 5,399 2.2 5,287 2.1

202001 341 264,045 5,288 2.0 4,652 1.8

202002 340 248,375 3,821 1.5 3,283 1.3

202003 341 243,157 3,592 1.5 3,391 1.4

202004 344 243,758 3,835 1.6 3,849 1.6

202005 346 253,620 4,524 1.8 4,679 1.8

202006 342 253,589 4,398 1.7 4,756 1.9

202007 346 247,514 4,133 1.7 4,053 1.6

202008 346 245,616 3,611 1.5 3,459 1.4

202009 345 243,967 3,580 1.5 3,485 1.4

202010 354 248,311 4,283 1.7 3,971 1.6

202011 354 247,058 6,907 2.8 6,125 2.5

202012 356 191,023 10,090 5.3 7,352 3.8

202013 358 151,779 8,334 5.5 4,863 3.2

202014 360 132,994 7,686 5.8 3,520 2.6

202015 360 128,390 7,666 6.0 2,829 2.2

202016 360 128,640 7,478 5.8 2,254 1.8

202017 360 136,594 7,626 5.6 2,059 1.5

202018 362 144,852 7,556 5.2 1,816 1.3

202019 359 150,027 6,900 4.6 1,565 1.0

202020 367 157,845 5,949 3.8 1,438 0.9

202021 368 170,167 5,553 3.3 1,421 0.8

202022 367 179,367 4,520 2.5 1,090 0.6

Total 7,425,975 166,795 108,805




Reporting




Visits

201940 816 612,182 8,566 1.4 7,573 1.2

201941 817 595,635 8,667 1.5 7,871 1.3

201942 820 592,999 9,283 1.6 8,209 1.4

201943 819 602,718 9,905 1.6 8,859 1.5

201944 844 599,239 10,755 1.8 9,893 1.7

201945 844 606,250 12,472 2.1 11,438 1.9

201946 860 595,852 13,192 2.2 12,172 2.0

201947 867 620,128 14,196 2.3 13,276 2.1

201948 866 600,127 15,305 2.6 14,573 2.4

201949 870 634,561 13,945 2.2 12,884 2.0

201950 876 638,747 14,585 2.3 14,754 2.3

201951 873 640,703 16,995 2.7 18,139 2.8

201952 875 661,475 20,781 3.1 22,582 3.4

202001 875 678,264 17,778 2.6 16,779 2.5

202002 876 643,033 12,826 2.0 12,219 1.9

202003 875 650,745 13,137 2.0 13,393 2.1

202004 879 626,909 13,681 2.2 13,723 2.2

202005 882 661,313 16,452 2.5 17,033 2.6

202006 882 674,823 17,056 2.5 17,656 2.6

202007 884 657,554 14,701 2.2 14,823 2.3

202008 885 641,487 13,405 2.1 12,850 2.0

202009 888 625,583 12,481 2.0 11,789 1.9

202010 889 641,525 15,788 2.5 15,013 2.3

202011 890 646,684 23,002 3.6 21,001 3.2

202012 890 527,948 29,298 5.5 23,371 4.4

202013 892 418,735 23,837 5.7 15,688 3.7

202014 889 351,968 17,693 5.0 9,972 2.8

202015 890 332,897 13,660 4.1 6,889 2.1

202016 893 331,533 10,937 3.3 5,091 1.5

202017 889 347,926 9,507 2.7 4,163 1.2

202018 891 357,580 8,635 2.4 3,655 1.0

202019 891 384,115 7,889 2.1 3,187 0.8

202020 894 399,873 7,875 2.0 3,088 0.8

202021 894 424,825 7,733 1.8 2,980 0.7

202022 896 439,308 7,048 1.6 2,886 0.7

Total 19,465,244 483,066 409,472




Reporting




Visits

201940 694 405,305 3,896 1.0 3,279 0.8

201941 690 394,827 4,241 1.1 3,492 0.9

201942 687 389,605 4,666 1.2 3,871 1.0

201943 690 395,302 4,810 1.2 4,048 1.0

201944 694 381,948 4,819 1.3 3,968 1.0

201945 700 388,198 5,266 1.4 4,277 1.1

201946 698 381,783 5,261 1.4 4,421 1.2

201947 699 402,330 5,831 1.4 4,941 1.2

201948 698 382,074 6,710 1.8 5,820 1.5

201949 699 414,221 7,283 1.8 6,380 1.5

201950 699 411,958 8,158 2.0 7,580 1.8

201951 701 411,841 8,881 2.2 9,043 2.2

201952 700 438,992 12,120 2.8 13,177 3.0

202001 706 451,505 11,230 2.5 11,446 2.5

202002 706 421,593 7,740 1.8 7,993 1.9

202003 708 403,222 7,154 1.8 8,080 2.0

202004 716 414,731 7,945 1.9 9,381 2.3

202005 716 435,927 9,735 2.2 12,364 2.8

202006 715 432,253 9,253 2.1 12,110 2.8

202007 715 413,411 8,196 2.0 10,380 2.5

202008 716 419,335 7,752 1.8 9,794 2.3

202009 717 411,164 7,174 1.7 8,836 2.1

202010 715 418,021 7,668 1.8 9,164 2.2

202011 714 416,305 12,044 2.9 12,617 3.0

202012 715 326,993 18,098 5.5 14,720 4.5

202013 715 258,795 16,602 6.4 9,833 3.8

202014 714 228,925 15,064 6.6 7,085 3.1

202015 712 215,714 12,896 6.0 4,889 2.3

202016 711 211,552 11,278 5.3 3,909 1.8

202017 715 228,925 11,269 4.9 3,614 1.6

202018 712 242,358 11,263 4.6 3,268 1.3

202019 714 249,370 10,000 4.0 2,635 1.1

202020 712 257,105 8,984 3.5 2,412 0.9

202021 715 278,272 8,030 2.9 2,143 0.8

202022 715 298,781 6,236 2.1 1,760 0.6

Total 12,632,641 307,553 242,730




Reporting




Visits

201940 366 204,791 2,143 1.0 1,897 0.9

201941 368 195,975 2,211 1.1 1,942 1.0

201942 365 197,774 2,581 1.3 2,276 1.2

201943 368 194,983 2,646 1.4 2,459 1.3

201944 371 189,734 2,977 1.6 2,826 1.5

201945 369 208,087 3,915 1.9 3,756 1.8

201946 371 206,179 4,268 2.1 4,106 2.0

201947 378 223,026 5,008 2.2 5,060 2.3

201948 371 207,133 5,162 2.5 4,988 2.4

201949 374 213,113 4,374 2.1 4,066 1.9

201950 378 210,097 4,049 1.9 4,043 1.9

201951 367 205,657 4,430 2.2 4,737 2.3

201952 370 219,230 5,847 2.7 6,452 2.9

202001 380 218,927 4,777 2.2 4,868 2.2

202002 379 204,740 3,578 1.7 3,567 1.7

202003 379 208,002 3,417 1.6 3,651 1.8

202004 383 203,281 3,712 1.8 4,221 2.1

202005 387 208,371 4,203 2.0 4,666 2.2

202006 383 202,820 4,139 2.0 4,485 2.2

202007 390 198,093 3,794 1.9 4,010 2.0

202008 396 199,838 3,732 1.9 3,856 1.9

202009 398 193,800 3,388 1.7 3,394 1.8

202010 402 201,347 4,020 2.0 4,003 2.0

202011 406 204,131 6,238 3.1 5,750 2.8

202012 403 167,188 8,624 5.2 6,781 4.1

202013 404 126,350 7,348 5.8 4,775 3.8

202014 412 113,445 5,830 5.1 3,082 2.7

202015 414 117,437 5,291 4.5 2,456 2.1

202016 413 115,643 3,894 3.4 1,605 1.4

202017 404 124,231 3,565 2.9 1,434 1.2

202018 409 129,185 3,360 2.6 1,331 1.0

202019 402 136,452 3,065 2.2 1,165 0.9

202020 401 140,371 3,035 2.2 1,236 0.9

202021 414 154,452 3,046 2.0 1,180 0.8

202022 436 170,195 2,975 1.7 1,126 0.7

Total 6,414,078 144,642 121,250




Reporting




Visits

201940 229 84,511 933 1.1 973 1.2

201941 228 80,966 1,037 1.3 1,066 1.3

201942 229 84,366 1,311 1.6 1,378 1.6

201943 229 83,388 1,381 1.7 1,387 1.7

201944 228 78,917 1,330 1.7 1,331 1.7

201945 228 83,334 1,492 1.8 1,520 1.8

201946 225 80,981 1,581 2.0 1,535 1.9

201947 226 86,526 1,819 2.1 1,853 2.1

201948 230 81,873 2,028 2.5 2,064 2.5

201949 230 87,879 2,000 2.3 1,990 2.3

201950 228 86,999 2,239 2.6 2,308 2.7

201951 231 83,716 2,567 3.1 2,691 3.2

201952 231 91,603 3,197 3.5 3,416 3.7

202001 239 92,083 2,811 3.1 2,874 3.1

202002 234 84,564 2,010 2.4 2,025 2.4

202003 236 82,891 1,891 2.3 2,057 2.5

202004 241 82,416 1,837 2.2 2,080 2.5

202005 244 87,678 2,222 2.5 2,558 2.9

202006 242 87,898 2,355 2.7 2,726 3.1

202007 244 87,167 2,520 2.9 2,889 3.3

202008 244 90,109 2,500 2.8 2,794 3.1

202009 247 88,985 2,247 2.5 2,563 2.9

202010 249 88,481 2,234 2.5 2,425 2.7

202011 250 85,783 2,815 3.3 2,851 3.3

202012 251 70,691 3,466 4.9 3,144 4.4

202013 253 58,084 2,612 4.5 2,072 3.6

202014 253 51,036 1,841 3.6 1,294 2.5

202015 251 49,661 1,398 2.8 882 1.8

202016 251 47,396 1,137 2.4 652 1.4

202017 251 51,569 1,100 2.1 620 1.2

202018 251 55,650 1,142 2.1 504 0.9

202019 252 56,747 1,010 1.8 443 0.8

202020 251 58,435 974 1.7 461 0.8

202021 251 62,916 789 1.3 403 0.6

202022 251 66,983 755 1.1 413 0.6

Total 2,682,282 64,581 62,242



Week

Number of Facilities

Reporting Total Number of

ED Visits


Number Percent of Total Visits Number

Percent of Total Visits

201940 152 47,376 367 0.8 285 0.6

201941 153 47,036 431 0.9 303 0.6

201942 152 47,911 436 0.9 333 0.7

201943 150 46,889 385 0.8 340 0.7

201944 156 46,009 427 0.9 316 0.7

201945 158 53,766 592 1.1 477 0.9

201946 159 54,376 606 1.1 484 0.9

201947 155 55,432 698 1.3 630 1.1

201948 158 52,879 844 1.6 752 1.4

201949 158 56,513 731 1.3 633 1.1

201950 162 56,044 814 1.5 765 1.4

201951 160 56,700 913 1.6 919 1.6

201952 158 59,679 1,433 2.4 1,513 2.5

202001 161 63,213 1,263 2.0 1,354 2.1

202002 161 60,878 1,193 2.0 1,165 1.9

202003 161 60,113 1,095 1.8 1,180 2.0

202004 161 62,395 1,334 2.1 1,415 2.3

202005 161 63,955 1,554 2.4 1,680 2.6

202006 165 61,605 1,394 2.3 1,461 2.4

202007 166 61,167 1,276 2.1 1,396 2.3

202008 161 61,824 1,342 2.2 1,456 2.4

202009 164 61,222 1,284 2.1 1,332 2.2

202010 164 61,997 1,435 2.3 1,517 2.4

202011 163 61,644 2,507 4.1 2,295 3.7

202012 161 50,037 3,118 6.2 2,369 4.7

202013 163 42,250 2,803 6.6 1,643 3.9

202014 164 37,698 2,448 6.5 1,221 3.2

202015 161 36,857 1,968 5.3 857 2.3

202016 163 35,451 1,574 4.4 599 1.7

202017 163 39,538 1,586 4.0 536 1.4

202018 163 41,618 1,481 3.6 434 1.0

202019 166 42,044 1,327 3.2 422 1.0

202020 166 43,253 1,230 2.8 350 0.8

202021 167 47,093 1,195 2.5 379 0.8

202022 169 48,729 969 2.0 347 0.7

Total 1,825,191 44,053 33,158




Reporting




Visits

201940 135 130,068 1,273 1.0 1,113 0.9

201941 135 132,247 1,464 1.1 1,211 0.9

201942 136 132,259 1,589 1.2 1,375 1.0

201943 137 134,307 1,708 1.3 1,535 1.1

201944 137 133,215 1,888 1.4 1,653 1.2

201945 141 143,855 2,356 1.6 2,304 1.6

201946 142 147,619 2,584 1.8 2,685 1.8

201947 140 144,933 2,514 1.7 2,688 1.9

201948 140 126,374 2,500 2.0 2,527 2.0

201949 139 143,642 2,776 1.9 2,697 1.9

201950 139 145,186 2,720 1.9 2,724 1.9

201951 138 143,692 2,921 2.0 2,929 2.0

201952 140 136,008 3,798 2.8 4,018 3.0

202001 138 147,165 4,021 2.7 4,028 2.7

202002 140 153,881 3,365 2.2 3,411 2.2

202003 140 155,275 3,293 2.1 3,667 2.4

202004 139 157,384 3,996 2.5 4,290 2.7

202005 139 159,949 4,351 2.7 4,646 2.9

202006 138 154,350 4,022 2.6 4,209 2.7

202007 138 153,379 3,956 2.6 4,009 2.6

202008 138 156,559 3,822 2.4 3,885 2.5

202009 139 153,328 3,228 2.1 3,259 2.1

202010 139 150,395 3,737 2.5 3,659 2.4

202011 140 143,239 5,049 3.5 4,575 3.2

202012 138 110,526 6,458 5.8 5,097 4.6

202013 138 86,779 5,058 5.8 3,371 3.9

202014 138 76,591 4,231 5.5 2,498 3.3

202015 137 71,085 3,335 4.7 1,719 2.4

202016 139 73,608 2,699 3.7 1,257 1.7

202017 139 79,380 2,694 3.4 1,154 1.5

202018 139 83,397 2,536 3.0 1,053 1.3

202019 140 86,299 2,351 2.7 989 1.1

202020 138 88,674 2,247 2.5 896 1.0

202021 137 93,681 2,246 2.4 1,095 1.2

202022 139 92,143 1,921 2.1 869 0.9

Total 4,420,472 108,707 93,095




Reporting




Visits

201940 191 91,396 724 0.8 490 0.5

201941 188 91,935 715 0.8 499 0.5

201942 192 92,926 802 0.9 616 0.7

201943 188 92,043 792 0.9 575 0.6

201944 190 87,908 773 0.9 596 0.7

201945 191 89,311 927 1.0 744 0.8

201946 191 95,104 1,123 1.2 956 1.0

201947 194 95,335 1,125 1.2 1,059 1.1

201948 193 91,758 1,375 1.5 1,350 1.5

201949 193 98,035 1,452 1.5 1,353 1.4

201950 192 98,605 1,730 1.8 1,802 1.8

201951 193 99,585 1,985 2.0 2,240 2.2

201952 194 103,326 2,609 2.5 2,992 2.9

202001 194 104,122 2,311 2.2 2,462 2.4

202002 196 98,070 1,627 1.7 1,571 1.6

202003 193 92,644 1,367 1.5 1,283 1.4

202004 193 97,725 1,439 1.5 1,432 1.5

202005 194 96,951 1,694 1.7 1,714 1.8

202006 193 94,999 1,630 1.7 1,502 1.6

202007 197 96,709 1,567 1.6 1,482 1.5

202008 195 97,828 1,706 1.7 1,554 1.6

202009 195 98,123 1,891 1.9 1,711 1.7

202010 196 97,387 3,208 3.3 2,995 3.1

202011 195 92,793 4,625 5.0 3,898 4.2

202012 195 77,059 5,355 6.9 3,896 5.1

202013 197 62,884 4,112 6.5 2,417 3.8

202014 195 56,286 3,150 5.6 1,410 2.5

202015 194 56,811 2,402 4.2 1,001 1.8

202016 195 57,661 1,769 3.1 640 1.1

202017 194 61,419 1,613 2.6 626 1.0

202018 194 64,913 1,414 2.2 560 0.9

202019 196 67,297 1,163 1.7 445 0.7

202020 194 69,968 1,110 1.6 440 0.6

202021 194 71,459 1,008 1.4 403 0.6

202022 194 76,683 935 1.2 387 0.5

Total 3,017,058 63,228 49,101


NCHS Mortality Surveillance Data For the Week Ending May 30, 2020 (Week 22)


Year Week Total Deaths Pneumonia, Influenza or

COVID-19 Deaths Baseline Threshold Number % of Total

2019 40 52,548 2,729 5.2 5.3 5.7 2019 41 53,079 2,798 5.3 5.4 5.7 2019 42 54,319 3,007 5.5 5.5 5.8 2019 43 54,026 3,026 5.6 5.6 5.9 2019 44 54,061 2,955 5.5 5.7 6.0 2019 45 55,618 3,104 5.6 5.8 6.2 2019 46 55,828 3,140 5.6 5.9 6.3 2019 47 56,104 3,058 5.5 6.0 6.4 2019 48 55,343 3,058 5.5 6.2 6.5 2019 49 57,242 3,425 6.0 6.3 6.6 2019 50 57,609 3,591 6.2 6.4 6.7 2019 51 57,375 3,508 6.1 6.5 6.8 2019 52 58,393 3,731 6.4 6.6 6.9 2020 1 59,772 4,485 7.5 6.7 7.0 2020 2 60,168 4,562 7.6 6.7 7.1 2020 3 58,707 4,449 7.6 6.8 7.2 2020 4 58,111 4,319 7.4 6.9 7.2 2020 5 57,683 4,201 7.3 6.9 7.3 2020 6 58,305 4,234 7.3 7.0 7.3 2020 7 57,659 4,295 7.4 7.0 7.3 2020 8 57,736 4,181 7.2 7.0 7.3 2020 9 58,101 4,381 7.5 7.0 7.3 2020 10 58,240 4,500 7.7 7.0 7.3 2020 11 57,103 4,497 7.9 6.9 7.3 2020 12 57,621 5,241 9.1 6.9 7.2 2020 13 61,437 8,024 13.1 6.8 7.1 2020 14 69,647 14,632 21.0 6.7 7.1 2020 15 75,526 20,174 26.7 6.7 7.0 2020 16 72,408 19,939 27.5 6.6 6.9 2020 17 67,883 17,175 25.3 6.5 6.8 2020 18 62,268 14,043 22.6 6.4 6.7 2020 19 58,876 12,427 21.1 6.3 6.6 2020 20 52,782 9,555 18.1 6.2 6.5 2020 21 39,579 5,428 13.7 6.0 6.4 2020 22 19,834 1,662 8.4 6.0 6.3

Documents

Outpatient and Emergency Department Visits2020/06/05 · in people aged 65 years and older (254.7 per 100,000) and 50-64 years (126.2 per 100,000). certificates are processed Based